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Cytochrome bc complexes in Respiration and Photosynthesis 
 
Ubiquinol-cytochrome c oxidoreductase, also known as complex III or 
cytochrome bc1 complex, which belongs to the superfamily of ‘bc complexes’, is present 
in the inner membrane of the mitochondria (Fig. 1) or in the cytoplasmic membrane of 
many bacteria (1-5).  Cytochrome bc1 complex, the central component of the energy-
conserving electron transfer pathway for their respiration or photosynthesis, catalyzes 
electron transfer from ubiquinol to soluble c-type cytochromes (cytc in mitochondria, 
cytc2 in some bacteria) with concomitant generation of a proton gradient and membrane 
potential, which is referred to as proton motive force (pmf).  The proton motive force is 
the driving force for synthesis of ATP by the complex V (F1F0-ATP synthase) (Fig. 1) in 
the inner mitochondria membrane.  
 All cytochrome bc1 complexes contain three core subunits, cytochrome b, 
cytochrome c1, and Reiske iron-sulfur protein (ISP), which house two b-type hemes (bL  
and bH), one c-type heme (heme c1), and a high potential [2Fe-2S] cluster (6), 











       
In mitochondria, the cytochrome bc1 complex is a part of the respiratory electron 
transport chain.  The electrons derived from glucose and fatty acids oxidation are 
transferred to the NAD+ and FAD to form NADH and FADH2 in the reactions catalyzed 
by the glycolytic enzymes, β-oxidation enzymes and the citric acid cycle enzymes 
(Fig.2.).  The electrons, from reoxidation of NADH and FADH2, pass through the 
electron-transport chain, composed of four complexes: NADH-ubiquinol reductase 
(complex I) (7) (Fig.1.), succinate-ubiqinol reductase (complex II), ubiquinol-cytochrome 
c reductase (complex III or cytochrome bc1 complex), and cytochrome c oxidase 
(complex IV), to generate the pmf as mentioned above.  
In addition to the respiratory system, the cytochrome bc1 complex is also found in 
the electron transport system of purple photosynthetic bacterium.  In the facultative 
photosynthetic purple nonsulfur bacterium Rhodobacter sphaeroides, the first steps of the 
conversion of light into chemical energy are accomplished by a cyclic electron transfer 
system, which generates a proton gradient across the chromatophore membrane.  Photo-
induced cyclic electron transfer involves two large transmembrane multiprotein 
complexes, the reaction center (RC) and the cytochrome bc1 complex, functionally 
connected through redox reactions of quinone in the lipid phase and of a water soluble 
protein (cytochrome c2) in the periplasmic phase (8).  Absorption of one photon leads to 
photo-oxidation of the primary electron donor, P870 (a bacteriochlorophyll), of the RC, 
which delivers an electron through a bacteriopheophytin to the primary quinone acceptor 
QA.  The electron is then transferred inside the reaction center to the secondary quinone 
acceptor QB, which, equilibrates with the Q-pool in the membrane following its full 























       
the substrate for the cytochrome bc1 complex reaction.  Same as in the mitochondrial bc1 
complex, for every mole of QH2 that is oxidized, two moles of cytochrome c2 are 
reduced, and four moles of proton are translocated across the membrane.   The cycle is 
completed by re-reduction of the photo-oxidized P870 by reduced cytochrome c2 (10).  In 
many other purple bacteria, like Rhodopseudomonas viridis, a RC-bound tetraheme 
cytochrome c, containing two high-potential and two low-potential hemes, acts as the 
immediate electron donor to P870 (10) (Fig. 3).  Therefore, in the cyclic pathway, there is 
no exogenous electron donor or a final electron acceptor.  Electrons continuously recycle 
between the reaction center and the bc1 complex with light energy serving as the driving 
force, resulting protons pumped across the membrane to form the proton motive force. 
The cytochrome b6f complex, plastoquinol-plastocyanin oxidoreductase, which also 
belongs to superfamily of bc complex, functions in the electron transport chains of 
oxygenic photosynthesis carried out by algae, Chlamydomonas reinhardtii (11), 
thermophilic cyanobacteria, Mastigocladus laminosus (12) and higher plants.  The 
multisubunit b6f membrane protein complex mediates electron transfer between the 
photosystem II, in which H2O is the electron donor, and the photosystem I. Consistent 
with a basic paradigm of membrane energy transduction (13), electron transfer through 
the b6f complex is coupled to proton translocation across the membrane.  The transfer of 
protons across the b6f complex, utilizing oxidation and reduction of lipophilic quinone, 
establishes a proton electrochemical potential gradient across the membrane that is 
negative on the stromal side and positive on the  thylakoid lumenal side (14-18).  The 
chloroplast b6f complex is a dimer and comprised of 8–9 subunits (4–5 large and 3–4 









Fig.3. Photosynthetic electron-transport system of purple 
photosynthetic bacteria.  (a)  A schematic diagram indicating the 
arrangement of the system components in the bacterial plasma 
membrane and the flows of electrons (black arrows) and protons (blue 
arrows) that photon (hυ) absorption promotes through them.  (b) The 
approximate standard reduction potentials of the photosynthetic 









       
one c-type heme, cytochrome b6, which contains two b-type hemes, subunit IV, and a 
Rieske iron-sulfur protein which contains one [2Fe-2S] cluster.  The cytochrome b of 
mitochondrial complex III is a fusion of chloroplast cytochrome b6 and subunit IV.  The 
cytochrome b subunit of the cytochrome b6f complex corresponds to the N-terminal 
heme-bearing part of bc1 complex’s cytochrome b subunit, while a sequence similar to 
the C-terminal part presents in subunit IV (21,22).  The Rieske iron-sulfur proteins in the 
two complexes are homologous and structurally similar.  However, cytochrome f is 
unrelated to its counterpart in complex III, cytochrome c1 although both are c-type 
cytochromes (19).  Moreover, there are at least three small subunits in higher plant 
cytochrome b6f, called PetA, PetM and PetL subunit (23-26). 
The photosynthetic pathway occurring in chloroplast with cytochrome b6f 
complexes is very complicated.  There are two photosynthetic systems in this pathway, 
photosystem I (PSI) and photosystem II (PSII), the latter is equivalent to the reaction 
center in R. sphaeroides.  In chloroplast, water is the electron donor for the 
photosynthesis.  Electrons are released from a water splitting reaction mediated by a Mn-
containing protein complex, and O2 is also generated in this reaction.  Plastoquinol (PQ), 
equivalent to ubiquinol, which is reduced in photosystem II, transfers an electron through 
the cytochrome b6f complex to plastocyanin (PC), functional analog of cytochrome c.  
The reduce PC then transfers the electron to photosystem I, whose redox potential is low 
enough to reduce NADP+.  After being excited by light energy, photosystem I transfers 
the electron to NADP+ and produces NADPH via an NADP reductase.  Therefore, a 
strong electron donor (NADPH) is produced by this pathway in addition to generating the 





       
complex in a cyclic process that only translocated protons into the thylakoid lumen 
(Fig.4.).  
 
Proton-motive Q cycle 
 
 The proton-motive Q-cycle model (27, 28), which was first proposed by Mitchell 
(27) and modified later (7, 29, 30), has been favored for describing electron transfer, the 
proton translocation, the 2:1 H+/e- ratio and the “oxidant-induced reduction of 
cytochrome b” in the cytochrome bc1 complex.  There are two features for this Q-cycle 
mechanism (7, 29, 31, 32) (Fig.5.).  (1) The presence of two separate 
ubiquinol/ubiquinone binding sites; an ubiquinol oxidation site (Qo) near the P (inter-
membranes space) side of the mitochondrial inner membrane, and a ubiquinone reduction 
site (Qi) near the N (matrix) side.  (2) The bifurcated electron transfer at the Qo site.  The 
mechanism of ubiquinol oxidation at Qo site involves a divergent oxidation in which the 
ubiquinol at the Qo site is oxidized by ISP and  cytochrome bL (4, 33) either in a 
concerted mechanism (34-37) or in a sequential mechanism (38-42).  In the concerted 
mechanism, oxidation of ubiquinone requires that both the iron-sulfur protein and 
cytochrome bL be oxidized and that cytochrome bL reduction precedes iron-sulfur protein 
reduction of cytochrome c1 (36). In the sequential mechanism, the iron-sulfur protein 
oxidizes the quinol to semiquinone, which then reduces cytochrome bL (Fig.5B).  
However, the presence of such semiquinone has not been detected (35, 43).  
In both mechanisms, two protons are released into the positive side of the 











Fig.4. Detailed diagram of the photosynthesis.  OEC, oxygen evolving complex; FQR, 










Fig.5. The proton motive Q cycle with (A) concerted and (B) sequential  









       
through the high potential chain, which has been transferred to ISP, heme c1 and then to 
heme c (c2 in bacteria).  The other electron is transferred through the low potential chain, 
which has been transferred to heme bL and heme bH.  At the Qi site, a ubiquinone (Q) 
accepts an electron from the bH heme to form a relatively stable ubisemiquinone (Q· P־ ).  
At this point, the reaction is only half complete, with only one of the two electrons from 
the ubiquinol being transferred to cytochrome c.  In the second half of the Q cycle, all 
steps are repeated: one ubiquinol is oxidized, one cytochrome c is reduced, two protons 
are deposited into the positive side of the membrane, and the b  heme is reduced via the 
b  heme.  At the Qi site, the ubisemiquinone, which is generated in the first half of the Q 
cycle, accepts another electron from the b  heme and uptakes two protons from the 
negative side of the membrane to form ubiquinol (QH ) and complete one Q cycle.  The 
net result of one complete Q cycle generates one molecule of oxidized ubiquinone, two 
molecules of reduced cytochrome c, uptake two protons from the negative side of the 





QH2 + 2 cyt c3+ + 2H+ (N-side)                  Q + 2 cyt c2+ + 4H+ (P-side)
 The proton motive Q-cycle mechanism is supported by many biophysical and 
biochemical experimental results: 
a) It accounts for the oxidant-induced cytochrome b reduction phenomenon.  
            A pulse of oxygen induces oxidation of cytochrome c and c1, which is 
accompanied by a transient reduction of cytochrome b.  Rapid oxidation of the c-
type cytochromes and ISP accelerated ubiquinol oxidation, resulting in a transient 
increased reduction of cytochrome b.  Antimycin blocks reoxidation of bH, 





       
ferricyanide, not only cytochrome c1 becomes oxidized as expected but 
cytochrome b is reduced (46).  
b)  There are two groups of inhibitors that bind to Qi and Qo sites.  Qo site inhibitors 
block the oxidation of ubiquinol, whereas the Qi site inhibitors block the electron 
transfer from heme bH to quinone or semiquinone (4, 7, 47-49).  Class I inhibitors 
are further divided into three sub-classes (Ia, Ib, and Ic) based on chemical 
characteristics of the inhibitors, and on spectroscopic and biophysical effects of 
the bL heme and the iron-sulfur cluster of ISP upon binding of the inhibitors. 
Class Ia inhibitors typically contain a β-methoxyacrylate (MOA) group (or a close 
chemical analogue) as a characteristic structural element and are referred to as the 
MOA inhibitors; they presumably block the electron transfer from quinol to the 
ISP, accompanying a red shift in the α and β-bands of the reduced heme bL 
spectrum.  Examples of the class Ia inhibitors are MOAS and myxothiazol.  Class 
Ib inhibitors possess a chromone ring system and are believed to inhibit electron 
transfer from ISP to cyt c1; they generate a pronounced increase in redox potential 
of the ISP and, like class Ia inhibitors, also cause a red shift of the reduced heme 
bL spectrum. Stigmatellin is a representative of class Ib inhibitors.  Class Ic 
inhibitors are 2-hydroxy quinone analogues such as 5-undecyl-6-hydroxy-4,7-
dioxobenzothiazole (UHDBT); they block the electron transfer in a similar way to 
the chromone inhibitors, but cause a smaller positive redox potential shift of the 
ISP and have no effect on the spectrum of the bL heme.  Azoxystrobin (56) and  
famoxadone (51) also belong to Class I inhibitors.  Antimycin belongs to class II 

















       
c)   Two protons being translocated across the membrane per one electron was   
observed during bc1 complex catalysis (53).   
      d)   A stable ubisemiquinone radical was detected in isolated mitochondrial bc1 
complex and the EPR signal from this semiquinone was eliminated upon addition 
of antimycin A (54), an inhibitor with higher affinity for Qi site than ubiquinone 
or ubisemiquinone. 
 
Three-Dimensional Crystal Structure of Cytochrome bc1 Complex 
 
 On the basis of x-ray diffraction data to a resolution of 2.9Å, atomic model of the 
bc1 complex from bovine heart mitochondria was first built by Chang-an Yu’s group in 
collaboration with Deisenhofer’s group in 1997 (55).  Crystallographic structures of 
mitochondrial bc1 complex from other sources such as chicken and yeast were available 
from other groups (56-58), and later the resolutions were improved to 2.4Å in the bovine 
bc1 complex structure (52).  
a) Structure overview: 
     An overall view of the cytochrome bc1 complex viewed parallel to the membrane 
is presented in Fig.7.  Two bc1 complex monomers interact in the crystal to form a dimer 
around a crystallographic twofold symmetry axis. The dimeric bc1 complex is pear- 
shaped with a maximal diameter of 130 Ǻ and a height of 155 Ǻ (55).  The cytochrome 
bc1 complex can be divided into three regions, the intermembrane space region, the trans-
membrane helix region and the matrix region.  The intermembrane space region is 










Fig.7. Ribbon model of the bovine dimeric cytochrome bc1 complex (59) from 
bovine heat mitochondria.  The molecule can be divided into three regions from 
the top to bottom: the intermembrane space region, membrane-spanning region 
and the matrix region.  The dimensions for each region of the molecule and the 













       
extending 38Ǻ into the cytoplasm from the membrane surface.  The transmembrane helix 
region is about 42Ǻ thick with thirteen transmembrane helices in each monomer. Most 
parts of cytochrome b are located within the membrane.  It has eight transmembrane 
helices, and the transmembrane region of cytochrome b houses heme bL, bH, and Qo, Qi 
pocket.  Subunit 7, 10, and 11 each has a transmembrane helix.  ISP and cytochrome c1 
each has a transmembrane anchor in their N-terminal and C-terminal, respectively.  Two 
symmetry related large cavities are found in the membrane spanning region, which are 
made of the transmembrane helices D, C, F and H in one monomer and helices D’ and E’ 
from the other monomer of cytochrome b, and the transmembrane helices of cytochrome 
c1, ISP subunit 10 and 11 (Fig.14A).   More than half of the molecular mass is located in 
the matrix region of the molecule, extending from the trans-membrane helix region by 
75Ǻ, which consists of core 1, core 2, subunit 6, and part of subunit 7 and subunit 9. 
Subunit core II and cytochrome b contribute major dimer interactions across the two-fold 
symmetry axis.  
b) Cytochrome b subunit: 
The cytochrome b subunit of the bovine bc1 complex has 379 amino acid residues 
and consists of eight membrane spanning helices named sequentially from A to H with 
both the N and C-terminal of cytochrome b subunit located in the mitochondrial matrix. 
The eight transmembrane helices of cytochrome b are arranged in two helical bundles: 
bundle I consists of the first five helices that incorporates two b-type hemes (bL and bH); 
bundle II is made of the rest of the helices.  The two helical bundles contact each other at 
the matrix site of the membrane but separate from each other at the intermembrane space, 





       
space side.  The CD loop contains two helices cd1 and cd2 of 15 and 9 residues, 
respectively, arranged in a hairpin, providing a “lid” for the Qo site and contributing 
residues to the docking site (the ISP crater) for interaction with ISP.  The EF loop bridges 
between the two helical bundles as well as takes part in the formation of the ISP 
interaction site.   Toward the end of the EF loop, there is a 12-residue helix, named ef, 
situated in a central position inside the Qo pocket.  The PEWY motif, conserved in all 
organisms, is found at the beginning of the helix (50, 51) (Fig.8). 
             The Qi pocket (52) is located near the matrix side of the membrane with its 
entrance open to the center of the membrane bilayer.  From the entrance, the cavity dives 
nearly vertically toward the matrix side of the membrane and is surrounded by residues 
from transmembrane helices A (Trp31, Asn32, Gly34, Ser35), D (Ala193, Met194, Leu197, 
His201), and E (Tyr224, Lys227, Asp228); the amphipathic surface helix a (Phe18); the A loop 
(Ile27); the DE loop (Ser205, Phe220); and atoms from the high-potential heme bH.  These 
residues are identified by their interactions with the bound antimycin A (Fig.9A), NQNO 
(Fig.9B), and substrate ubiquinone (Fig.9C) in the cytb subunit.  Among these residues, 
Ser35, His201, Lys227, Asp228, and Ser205 are highly conserved (Fig.10) and located near the 
bottom of the pocket. The Qi pocket has a hydrophobic entrance but turns progressively 
hydrophilic inward; it has the dimensions of roughly 7 x 10 x 13Å and is potentially 
capable of accessing the mitochondrial matrix through the conserved residues His201 and 
Lys227. 
The Qo pocket of the native bc1 complex (50) has the shape of a saddle.  With a 
relatively wide opening at one end, it becomes increasingly narrower moving inwards; 











Fig.8. Ribbon diagram of the dimeric cytb and ISP in the bc1 complex.  Two cytb 
subunits (labeled cytb in light blue and cytb-sym in green, respectively) and two ISP 
subunits (labeled ISP in yellow and ISP-sym in red, respectively) related by a molecular 
2-fold symmetry are shown.  The eight transmembrane helices of cytb are named 
sequentially from A to H.  The two b-type hemes labeled bL and bH are shown as the ball-
and-stick models.  Two active sites in the cytb are labeled: one is Qi site, the other is Qo 
site.  The surface depression in cytb on the inter-membrane space side is labeled as the 












Fig.9. Interactions of the protein environment at the Qi site of the cytb subunit with 
bound inhibitors and substrate.  Secondary structure elements surrounding the Qi pocket, 
including portions of the N-terminal helix a, transmembrane helices A, D, and E, and 
extramembrane loops A and DE, are shown and labeled.  Residues interacting with bound 
inhibitors or substrate and the bH heme are drawn in stick models and are labeled with 
carbon atoms in yellow, nitrogen in blue, oxygen in red, and iron in orange.  H-bonds are 
indicated with the pinkish dotted lines. Water molecules are shown as the isolated red 
balls.  Inhibitors and the substrate ubiquinone are drawn as the ball-and-stick models with 
carbon atoms in black, nitrogen in light blue, and oxygen in red. (A) Qi pocket with the 
bound antimycin A, (B) Qi pocket with the bound NQNO, and (C) Qi pocket with the 










      
       
end (Fig.11).  The Qo pocket is highly hydrophobic and lined with six prominent 
aromatic residues in addition to a number of aliphatic residues.  The pocket is delimited 
against the membrane by three transmembrane helices (B, C and E) and by the buried ef 
helix, and capped by the cd1 and cd2 helices isolating the Qo site from the 
intermembrane space.  Moreover, His161 of the ISP, ligand to one of the iron atoms in the 
2Fe-2S cluster, may also contribute to the Qo site when the ISP is bound at the Qo site. 
The Qo pocket is exceptionally rich in highly conserved residues (Fig.12). 
c) Iron-sulfur protein (ISP) 
The structure of Rieske iron-sulfur protein (ISP) can be divided into three domains: the 
N-terminal domain, tail domain, (residues 1-62); the flexible linking domain, neck region, 
(residues 63-72); the soluble C-terminal domain, head domain, (residues 73-196), which 
is located in the intermembrane space region.  The Rieske iron sulfur subunit is anchored 
to the membrane by the tail domain, and  no ordered secondary structure was reported in 
the neck region (55, 56).  In the bovine heart mitochondrial cytochrome bc1 complex, the 
[2Fe-2S] cluster is coordinated by two cysteine and two histidine residues (Cys139 and 
His141; Cys158 and His161) (60) (Fig.12.) within a C-terminal water soluble domain which 
is bound to the rest of the bc1 complex through this N-terminal membrane anchor (61, 62). 
In ISP, the [2Fe-2S] cluster is located at the tip of the head domain.  Moreover, ISPs 
extend across the interface between the two monomers, with the transmembrane helix in 
one monomer and the head domain within the other, thus forming the intertwining dimer 
(59).  
d) Cytochrome c1 subunit. 










Fig.11. Structural environment of the native Qo site.  The Qo pocket is depicted as a 
GRASP (63) surface with the surrounding secondary structure elements.  Helices cd1, 
cd2 and ef as well as parts of B, C, E and F helices are shown and labeled.  The heme bL 
of cytb, 2Fe-2S cluster of the ISP, and the conserved residues are also shown in the ball-














Fig.12. Sequence alignment of the Qo pocket residues.  The Qo site is composed of 
residues from two sequence segments: one from residue 120 to 182 and another from 
residue 250 to 300.  The sequence shown include BT (B. Taurus), SC (S. cerevisiae), 
SP (S. pombe), RC (R. capsulatus), RR (R. rubrum), SU (Sea Urchin, S. purpuratus), 
ST (S. tenacellus) and WT (wheat cytb6, T. aestivum).  Helical elements are indicated 
as green boxes and labeled.  Absolutely conserved residues in all sequences are 
colored red; highly conserved residues with one conserved change are colored blue; 




































       
with its physiological redox partners, soluble or membrane-attached cytochromes c or 
head domain of high-potential iron-sulfur proteins.  Cytochrome c1 provides a docking 
site for these proteins on its surface at the membrane-aqueous interface.  Cytochrome c1 
is oxidized by cytochrome c (in bacteria, cytochrome c2), in turn, the oxidized 
cytochrome c1 acts to oxidize the [2Fe2S] cluster, which then moves to the Qo site. 
Cytochrome c1 is attached to the membrane by a transmembrane helix located at the C-
terminal end of the protein.  The hydrophilic extramembrane domain including the heme 
is located in the intermembrane space region.  The extrinsic domain of cytochrome c1 
contains the consensus heme-binding motif (CXXCH) located close to the N-terminus of 
the polypeptide that provides sites for covalent attachment of the heme group (cysteines) 
and fifth axial ligation to the heme iron (histidine).  It also contains the invariant 
methionine residue present near the C-terminus that acts as the sixth axial ligand to the 
heme iron (56, 57, 64).  The carboxy group of one of the propionates of the heme c1 
forms a salt bridge with Arg120, while the other propionate of the heme c1 extends toward 
the ISP. A methyl group on the porphyrin ring is solvent-exposed, likely near the binding 
site for cytochrome c (6).  The x-ray crystal structures of beef and chicken cytochromes 
bc1 have revealed that the exposed heme CD edge of cytochrome c1 on the cytoplasmic 
surface of the membrane is surrounded by acidic residues that could form a docking site 
for cytochrome c (55-57).  The acidic residues (Glu74, Glu101, Asp102, Glu104, Asp109, 
Glu162, Glu163, and Glu168) on the surface of cytochrome c1 of R.  sphaeroides cytochrome 
bc1 complex are involved in binding positively charged cytochrome c.  These acidic 
residues on opposite sides of the heme crevice of cytochrome c1 direct the diffusion and 





       
Functional Indication from Structural Analysis 
of Cytochrome bc1 Complex 
 
 
a) Head domain movement of ISP 
      Mobility of ISP head domain in the bc1 crystal was first suggested by observation 
of a particularly low electron density of its extramembrane head domain (55).  The 
mobility of the head domain of ISP was further substantiated by the anomalous light 
scattering signals of the [2Fe-2S] cluster observed in native and co-crystals with various 
Qo site inhibitors.  In a native bovine heart mitochondrial bc1 crystal, a much weaker 
anomalous light scattering signal was observed for the [2Fe-2S] cluster compared with 
that for the heme iron, bH or bL, despite the presence of two irons in the cluster. 
Furthermore, the electron density of the anomalous light scattering signal of [2Fe-2S] 
cluster was strongly enhanced in a co-crystal with stigmatellin or UHDBT, indicating that 
these inhibitors arrest the mobility of ISP in the fixed state position (66), and ISP head 
domain is on the surface of cytochrome b (b position).  Conversely, the electron density 
of the anomalous scattering peak of [2Fe-2S] is abolished in a co-crystal with MOA-
stilbene or myxothiazol, indicating that these inhibitors increase the mobility of ISP in the 
crystal and [2Fe-2S] has no predominant position, the ISP head domain is in a released 
state and found at the c-interface (c1 position) (56, 67). 
The hypothesis of the mobility of the ISP head domain not only provides an 
explanation for the unexpected findings in those crystal structures, but it also provides an 
explanation for the bifurcated reaction at the Qo site.  The bifurcated quinol oxidation at 
the Qo site is the key step in the Q cycle mechanism as mentioned in the previous section. 





       
from quinol has to be transferred to the unfavorable low potential chain (cytochrome bL 
and bH).  It’s difficult to explain why both electrons are not moved to the 
thermodynamically favorable high potential chain (ISP and cytochrome c1).  On the other 
hand, in the bovine heart mitochondrial bc1 crystal, the distances between heme bL and 
the [2Fe-2S] cluster and between the [2Fe-2S] cluster and heme c1, are 27 and 31 Å, 
respectively.  Although the distance of 27 Å between heme bL and the [2Fe-2S] cluster 
accommodates well the observed fast electron transfer between these two redox centers, 
the 31 Å distance between the [2Fe-2S] cluster and heme c1 is difficult to understand in 
view of the rapid electron transfer rate observed for these two redox centers (32,68). 
Movement of the extramembrane domain of ISP offers an explanation for these 
paradoxes.  The [2Fe-2S] cluster is reduced by the first electron of ubiquinol at a position 
27 Å from heme bL and 31 Å from cytochrome c1.  The reduced [2Fe-2S] cluster cannot 
donate an electron to cytochrome c1 before the second electron of ubiquinol is transferred 
to heme bL.  It was speculated that the electron transfer from heme bL to bH causes a 
conformational change in cytochrome b that forces or allows reduced [2Fe-2S] to move 
close enough to heme c1 for fast electron transfer (6, 56).  This model also suggests that  
the re-oxidized ISP is unable to return to the b-position to be re-reduced, before the 
second electron is transferred to the low potential chain (40). 
 To study the movement of the head domain of ISP is required for bc1 catalysis  
and the neck region of ISP confers the necessary mobility, molecular biology, 
biochemical and biophysical methods were used.  Tian et al. (69) demonstrated that 
increasing the rigidity of the ISP neck region of the R. sphaeroides bc1 complex by a 





       
42-44 decreased the activity and increased the activation energy because the neck rigidity 
is increased in the mutant bc1 complexes.  In a continuous work, Tian et al (70) 
constructed mutants with cysteines pairs in the ISP neck region, Ala42 and Val44; Pro40 
and Ala42.  Oxidation of these two cystines pair to form a disulfide bond resulted in 
restricting the flexibility of the ISP neck region, in turn, decreased the mobility of the 
head domain, thus decreased activity of the bc1 complex, however, the activity can be 
restored by reducing the disulfide bond with β-mercaptoethanol.  The restored activity 
was diminished upon removal of β-mercaptoethanol but is retained if the β-
mercaptoethanol-treated membrane was treated with the sulfhydryl reagent N-
ethylmaleimide or p-chloromercuribenzoic acid.  To further establish the essentiality of 
the movement of the head domain of ISP, R. sphaeroides bc1 mutants with a pair of 
cysteines engineered on the interface between ISP and cytochrome b, A185C (cytb)/K70C 
(ISP) was generated and characterized (71).  Formation of the intersubunit disulfide bond 
in this cysteine pair mutant complex arrests the head domain of ISP in the “fixed state” 
position that is too far for electron transfer to heme c1, resulting in the loss of the bc1 
activity,  reduction of this disulfide bond by β-mercaptoethanol restores the activity. 
b) The intertwined dimeric structure of cytochrome bc1 complex 
The dimeric association of cytochrome bc1 complex has been reported extensively 
throughout the literature (72-74).  Recently, three dimensional structures of mitochondrial 
cytochrome bc1 complexes from beef (55, 57), chicken (56), and yeast (58) were 
determined.  The structural information suggests the complex functioning as a dimer.  
The functional dimer hypothesis is supported by the following structural evidences:  





       
cluster in one monomer is 27 Å from heme bL of the other monomer and 40 Å from the 
heme bL of the same monomer (55).  This structural arrangement suggests that 
mitochondrial bc1 complex functions as a dimer, because the distance between the [2Fe-
2S] cluster of ISP of one monomer and heme bL of the other monomer is less than that 
between these groups in the same monomer.  The shorter distance accommodates fast 
electron transfer from QH2 to ISP and bL.  Xiao et al (59) demonstrated that the structure 
of the dimeric cytochrome bc1 complex observed in the crystal also exists in solution. 
They constructed and characterized two pairs of cysteine substitutions, one in the 
interface between the head domain of ISP and cytochrome b and the other between the 
tail domain of ISP and cytochrome b.  An adduct protein containing two cytochrome b 
and two ISP proteins is detected in the mutant complexes, confirming that the bc1 
complex exists as a dimer which the intertwining of ISP in one monomer is physically 
close to and interacting with the cytochrome b and cytochrome c1 in the 2-fold symmetry-
related to the other monomer (Fig.7). 
             (2) The presence of two apparently non-communicating cavities in the dimeric 
complex, each connecting the Qo pocket of one monomer to the Qi pocket of the other. 
Interestingly the two quinone binding sites from the same monomer do not connect each 
other.  The membrane spanning cavity may help the transfer of quinone between Qo and 
Qi sites located on different monomers.  As a result of that, quinone reduced at Qi site of  
one monomer can be oxidized at the nearby Qo site of the other monomer without 
leaving the bc1 complex (Fig.14A). 




















Fig.14. Cytochrome bc1 exists as a functional and 
structural dimer.  (A) Q binding cavity between cytb 
dimer.  (B) Distance between redox centers in bovine 











       
approximately the same as that between heme bL and bH in one monomer (Fig.14B). 
Because of the short distance between the two hemes bL, the electron transfer or 
equilibrating between inter-monomer hemes bL-bL may occur during bc1 catalysis 
(37,55,76), and such electron transfer may be facilitated by the aromatic pairs present 
between the two hemes bL in the two symmetry-related monomers (Fig.15).  To test this 
hypothesis, Gong et al (75) constructed  and characterized R. sphaeroides mutants bc1 
complexes with mutations at three aromatic residues (Phe195, Tyr199, and Phe203). 
Replacing only Phe195 to Ala decreases slightly the ubiquinol-cytochrome c reductase 
activity and increases the production of superoxide several fold, not only suggesting that 
this mutation interfered with electron transfer between two monomers, but also 
supporting the idea that the interruption of the electron transfer between the two bL hemes 
enhance the electron leakage to oxygen and thus decreasing the activity.  On the other 
hand, replacing the Phe195 with Tyr, His, or Trp results in mutant complexes having the 
same ubiquinol-cytochrome c reductase activity as the wild-type, indicating that the 
aromatic group at the position 195 is involved in electron transfer reaction.  
 
 
Supernumerary Subunits of Cytochrome bc1 Complex 
 
 There are two kinds of protein subunits in the cytochrome bc1 complex, one are 
those contain a redox prosthetic group, such as heme bL , bH, c1, and iron-sulfur cluster, 
called the core subunits, the other are those that do not, called the supernumerary 
subunits (77).  All the bc1 complexes contain three core subunits, cytochrome b, 


























Fig.15. Location of aromatic residues in the structural model of the R. sphaeroides bc1 
complex. (A) cytb is shown in blue ribbon in one monomer and green in the symmetric 
monomer, ISP (from the symmetric monomer) is in yellow, and the cytc1 form the same 
monomer is in pink. Both subunit IVs, ISP (from one monomer) and cytc1 (from the 
symmetric monomer) are shown in turquoise.  All hemes are indicated by red sticks.  (B) 
shows the aromatic residues located on the interface of two bL hemes from different cytbs.  
The nearest edge to edge distances between aromatic residues from different monomers 






       
(77).  However, bc1 complexes from different sources contain varied numbers of 
supernumerary subunits (4,77).  Cytochrome bc1 complexes from some bacteria contain 
only three core subunits, this is the case with the enzyme from Paracoccus (78), 
Rhodospirillum rubrum (85), and Rhodobacter capsulatus (79).  Whereas the bc1 
complex from bovine heart mitochondria has eight supernumerary subunits (Fig.7) (81), 
that from yeast (82) has seven. Rhodobacter sphaeroides has only one, subunit IV 
(Fig.16A). 
 Although the function of supernumerary subunits are not fully understand, the 
complexes without supernumerary subunits are less stable and have lower activity than 
those with supernumerary subunits (82).  It has been reported that the activation of 
cytochrome bc1 complexes purified from the bovine mitochondria, yeast, and from the 
chromatophores of R. sphaeroides and R. capsulatus, by a single chromatographic 
procedure are: 1152, 219, 128, and 64s-1 (82).  The increased activity in mitochondria 
complex may result from interactions of the core subunits with supernumerary subunits.  
Some groups investigated the function of the supernumerary subunits of the 
mitochondrial cytochrome bc1 complex.  It’s shown that subunit I and II of yeast bc1 
complex  is essential for maintaining the proper conformation of apocytochrome b to aid 
in the addition of heme (83,84); subunit VI of yeast bc1 complex  is involved in 
manipulating dimmer/monomer transition (85,86); subunit VII and VIII of yeast bc1 
complex are essential for assembly of the complex (87); subunit IX of yeast bc1 complex 
interacts with the iron-sulfur protein, cytochrome b and cytochrome c1 (88); subunit I and 






       
The  gene of supernumerary subunit of R. sphaeroides, subunit IV (fbcQ), was 
cloned and sequenced (91).  The molecular weight, deduced from the nucleotide 
sequence, is 14,348 Da (92).  It is a relatively hydrophilic protein of 124 residues, with a 
transmembrane helix predicted at a hydrophobic stretch between residues 86 and 109 
based on the hydropathy analysis (91), the C-terminal end on the periplasmic side and the 
N-terminal end on the cytoplasmic side (93).  The interacting regions of subunit IV with 
cytochrome b in the core complex were identified as residues 41-53 and 77-85, which are 
on the cytoplasmic side of the chromatophore membrane and close to the DE loop and 
helix G of cytochrome b, respectively (94).   Moreover, subunit IV is involved in the 
structural role of the complex indicated by mutational effects with a delay in 
photosynthetic growth and decreasing in the cytochrome bc1 complex activity in 
chromatophores upon detergent treatment (95).  The ubiquinone-binding functions of 
subunit IV is supported by photoaffinity labeling using azido-Q derivatives (92) and an  
increasing in the apparent Km for 2,3-dimethoxy-5-methyl-6-geranyl-1,4-benzoquinol 
 (QH2) of the complex.  By using site-directed mutagenesis on the subunit IV gene 
followed by in vitro reconstitution, residues 6-11 are essential for structural function of 
subunit IV.  Trp79 is essential for the structural and ubiquinone binding functions of 
subunit IV (95).  Subunit IV was over-expressed in E. coli as a glutathione S-transferase 
fusion protein to solve the difficulty presented by mutagenesis studies by the in vivo 
reconstitution.  Subunit IV can then be released from the fusion protein by proteolytic 
cleavage with thrombin.  The recombinant subunit IV is functionally active and can be 
properly assembled into the active cytochrome bc1 complex without subunit IV (96).  By 





       
further study the function of subunit IV.  
  
 
Photosynthetic Bacteria: Rhodobacter sphaeroides 
 
 Our group uses R. sphaeroides bc1 complex as a model system to study 
successfully the more elaborate mitochondrial cytochrome bc1 complexes (6,59, 69-71, 
75, 94, 96).  R. sphaeroides, an anoxygenic, non-sulfur, purple facultative photosynthetic 
bacterium, belongs to gram-negative bacterium of the proteobacteria group.  Unlike 
plants and algae, which carry out photosynthesis in an aerobic environment and produce 
oxygen as a product of the water splitting reaction, R. sphaeroides carries out 
photosynthesis in an anaerobic condition, and does not produce oxygen.  Moreover, 
Rhodobacter sphaeroides is metabolically highly diverse.  It can grow photosynthetically 
or heterotrophyically via aerobic or anaerobic respiration (97).  It prefers to grow 
photoheterotrophically, under anaerobic conditions in light with various organic 
substrates.  Therefore, the ecological niches of R. sphaeroides are anoxic parts of water 
and sediments, which receive light of sufficient quantity and quality to allow 
phototrophic development (98).  Under aerobic conditions, it can grow well in the dark, 
as the synthesis of some photosynthetic pigments, for example, bacteriochlorophyll, in R. 
sphaeroides is repressed by oxygen (98), the culture becomes pink colored rather than 
brownish green as seen in photosynthetic cultures. 
 A very important feature of R. sphaeroides as a material for bc1 complex study is 





       
photosynthesis, since electron from quinol can be transferred to oxygen via a quinol 
oxidase as an alternative electron transfer pathway.  Therefore, R. sphaeroides mutants 
with severely defective bc1 complex are still able to grow in large quantities under 
aerobic conditions.  The bacteria growing under “semi-aerobic dark” conditions develop 
intra-cytoplasmic membrane (ICM) that most of the photosynthetic machinery of R. 
sphaeroides is located (98-100), intra-cytoplasmic membrane with defective bc1 complex 
can be prepared for biochemical and biophysical studies to assess the reasons of the 
defect.  
In addition, the bc1 complex from R. sphaeroides contains only four subunits 
(cytochrome b, cytochrome c1, ISP and subunit IV) with the three catalytic subunits 
(cytochrome b, cytochrome c1, ISP) homologous to their mitochondrial counterparts. It is 
much simpler than the mitochondrial complexes thus making it much easier for us to 
study structure-based functions of the bc1 complex.  Furthermore, efficient molecular 
engineering protocols for R. sphaeroides bc1 complex are well established (6).  (His)6-
tagged (69) on cytochrome c1 of the cytochrome bc1 complex is readily overexpressed in 
chromosomal deletion strain BC17 (lacking  fbcFBC operon) by a plasmid carrying the 
genes complementing them in trans, which greatly facilitates the isolation of the  bc1 
complex from cells using the nickel-nitrilotriacetic acid (Ni-NTA) agarose column. The 
purity, activity and cytochrome content of these histidine-tagged bc1 complexes are 
similar to those of the un-tagged ones.  Such genetic system has been used extensively to 
study site-directed mutants and proven to be extremely valuable for our knowledge of the 






       
Homology Structural Modeling and Extra Fragments of 
Rhodobacter sphaeroides bc1 Complex 
 
 The R. sphaeroides bc1 complex is functionally homologous to the mitochondrial 
complex.  However, since the R. sphaeroides bc1 complex contains only one 
supernumerary subunit, it’s unlikely that the structures of the core subunits in the 
complex is stabilized through interactions between core subunits and their neighboring 
supernumerary subunits, as suggested for the mitochondrial complex (108).  It’s possible 
that interactions between part of a core subunit and another part of the same subunit or 
another core subunit contribute to the stability of a core subunit in R. sphaeroides bc1 
complex.  This hypothesis finds some support from the fact that core subunits in R. 
sphaeroides bc1 complex are generally bigger than their counterparts in the mitochondrial 
complex due to specific insertions that are uniquely present in the core subunits. 
 Since the crystal structure of R. sphaeroides bc1 is unavailable at this time, the 
homology modeling is a practical way to predict its three dimensional structure based on 
the assumption that sequence conservation is directly proportional to structural 
conservation, a structure model of the R. sphaeroides bc1 complex was constructed using 
coordinates of subunits from bovine complex (6) (Fig.16A.).  Amino acid sequence 
alignment of R. sphaeroides cytochrome b, cytochrome c1, and ISP with their 
counterparts in the bovine mitochondrial bc1 complex reveals high sequence homology, 
except for several extra fragments in R. sphaeroides bc1 complex.  There are one extra 
fragment in ISP, two in cytochrome c1, four in cytochrome b.  By swapping coordinates 





       
sequence alignment, the majority of cytochrome b, cytochrome c1, and ISP were modeled. 
Subunit IV and the extra fragments of cytochrome b, cytochrome c1, and ISP were 
modeled with the coordinates from the corresponding supernumerary subunits in the 
bovine bc1 complex.  In the structure model of R. sphaeroides bc1 complex (6), the four 
extra fragments of cytochrome b are located at the N terminus (residues 2-12), the 
connecting loop between helices D and E ( residues 232-239), the connecting loop 
between helices E and F ( residues 309-326), and the C-terminus (residues 421-445); the 
two extra fragment of cytochrome c1 are located between helix α2 and helix α3 (residues 
109-125), and between  helix α4 and helix α5 (residues 161-179), respectively; the one 
extra fragment of ISP (residues 96-107) is located near the middle portion of the ISP.  The 
first two extra fragments of cytochrome b (residues 2-12, 232-239) are located on the 
cytoplasmic side of the chromatophore membrane; the third one (residues 309-326) is 
located near to heme bL, iron-sulfur cluster, and the Qo site; the forth one (residues 421-
445) is in close proximity to subunit IV and ISP, and also located on the cytoplasmic side 
of the chromatophore membrane (106).  The extra fragment of ISP shows an α-helical 
structure in the structure model (105) (Fig.16B.).  It was shown that the first two extra 
fragments of cytochrome b (residues 2-12, 232-239) contribute little effect on structural 
integrity of the bc1 complex.  Chapter III  and IV of this thesis will present evidence for 
the essentiality of the extra fragments of R. sphaeroides cytochrome b (residues 421-445) 
and ISP (residues 96-107) for maintaining structural integrity of the bc1 complex.  These 
findings support the idea that the extra fragments possess the supernumerary subunit 
function in stabilizing the structure of the bacterial complex.  The studies of other extra 











Fig.16. (A) Theoretical ribbon model of the R. sphaeroides dimeric cytochrome bc1 
complex.  ISP is red, cytb is green, cytc1 is silver, subunit IV is rust. (B) Location of the 
extra fragments of ISP, cytochrome b, and cytochrome c1 in the proposed structural 
model of R. sphaeroides cytochrome bc1 complex.  Cytc1 is shown in both monomers, 







       
 




Cytochrome c oxidase 
 
 Cytochrome c oxidase (or Complex IV) is the terminal oxidase of cell respiration, 
reducing molecular oxygen (O2) to water via a mechanism coupled with a proton 
pumping process.  The proton motive force produced by the proton pumping process and 
O2 reduction is energetically harnessed for production of ATP by ATP synthase (109).  
The mammalian cytochrome c oxidase enzyme is a large multicomponent membrane 
protein comprising 13 different subunits, four redox-active metal sites (hemes a and a3, 
CuA and CuB), three redox-inactive metal sites (Mg2+, Zn2+ and Na+) and several different 
classes of phospholipids(110).  Except for the redox-active metal sites, the roles of these 
components are essentially unknown.  The O2 reduction site comprises heme a3 (in high-
spin state in the oxidized state) and CuB (109).  Electrons from cytochrome c are accepted 
by CuA and transferred to the O2 reduction site via heme a (in six-coordinated low-spin 
state in both oxidation states (111)).  Although cytochrome c oxidases of bacteria are less 
complex, they do include the three largest subunits (subunits I, II, and III) that are 
common to those of the mammalian enzymes.  X-ray structures of bovine and bacterial 
enzymes indicate strong homology among the three-dimensional structures of these 
redox-active metal sites, providing convincing evidence for the existence of a conserved 
reaction mechanism (112). 
 It is believed that the protons are transferred through the D- and K-pathways in 
cytochrome c oxidase (113).  No amino acid residues in the pathway are completely 





       
could function in a physiologically identical process (113).  At present, X-ray structures 
of three bacterial oxidases have been solved at resolutions better than 2.8 Å (114-116). 
Two bacterial aa3-type cytochrome c oxidases have a glycine at the point corresponding 
to the site of Asp51 in bovine cytochrome c oxidase (114,116).  A small cavity capable of 
trapping a water molecule is located between the glycine and the peptide bond in the 
hydrogen-bond network.  The glycine–water combination is expected to be capable of 
transferring protons from the hydrogen-bond network to the periplasmic phase with a 
conformational change controlling the accessibility of the water molecule to the aqueous 
phase.  On the other hand, the ba3-type cytochrome oxidase of an extreme thermophilic 
bacterium does not have a pathway homologous to the H pathway, but it does contain 
another hydrogen-bond network which extends across the enzyme molecule (116).  These 




 Mitochondrial ATP synthase is the terminal enzyme in oxidative phosphorylation 
and produces the energy ATP for the cell.  It consists of two major units, F1 in the matrix, 
which binds ADP/ATP and catalyzes ATP synthesis and hydrolysis, and F0, which spans 
the inner mitochondrial membrane and directs protons to the F1 moiety.  As a result of 
this composition this enzyme is often referred to as F1F0 ATP synthase.  F1 is made up of 
the three α subunits, three β subunits, and one subunit each of γ, δ, and ε. F0 also contains 
multiple subunits including an oligomycin sensitivity conferring protein (OSCP), 10-12 c 
subunits involved in gating of the proton channel, an α subunit that facilitates transfer of 





       
to function as stators between F1 and F0 and two F6 subunits that also mediate sensitivity 
to oligomycin (117).  Also present in F0 are d, e, f, and g subunits that are found in close 
association with the OSCP subunit (118). 
 F1F0 ATPase is able to catalyze both ATP synthesis and hydrolysis.  The switch 
between these two activities is dependent on the proton gradient between the matrix and 
the inter membrane space.  ATPase can use the energy from ATP hydrolysis to pump 
proton into the intermembrane space or if a large enough proton gradient exists, use the 
proton flow through the complex (from inter membrane space to matrix) to drive ATP 
synthesis. 
 The 10-12 c subunits form a ring at the base of the γ subunit and the pumping of 
protons by the a subunit to the c ring and is thought to result in the turning of both the c 
ring and the entire F1 complex.  This rotation is believed to provide the energy for the 
synthesis of ATP by the F1 complex.  Tsunoda et al. showed that the ε subunit can exist in 
two conformations in the F1 complex (119).  When the ε subunit is perpendicular to the 
inner membrane, ATP hydrolysis is inhibited, proton pumping is inhibited, but ATP 
synthesis is not.  On the other hand, when the ε subunit is parallel to the inner membrane, 
ATP hydrolysis is activated and proton pumping functions normally, but there is no effect 
on ATP synthesis.  This data indicates that the ε subunit may be important in the 
regulation of switching between ATP synthesis and ATP hydrolysis. 
 Oligomycin is a specific inhibitor of ATP synthase.  It binds to the membrane 
portion of the F0 complex of the enzyme and inhibits proton translocation.  Sensitivity of 
ATP synthase to oligomycin appears to be mediated not only by the OSCP but also by the 
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Material and Methods 
 
 





 R. sphaeroides cells, wild-type and mutant were grown photosynthetically at 30°C 
in an enriched Sistrom medium containing 0.2% casamino acids and 5 mM glutamate (1, 
2), the pH of the medium was adjusted to 7.1 with the mixture of 6N NaOH and 2N KOH 
to increase the sodium and potassium ion content of the medium to a more optimal level 
(1).  When the cells reached the end of log growth phase, i.e., the density OD600 of the 
cell culture reached about 2.0, cells were harvested by centrifugation at 3,300 x g for 45 
minutes using Beckman J6-HC centrifuge and JS4.2 rotor.  The cells were suspended  
with buffer containing 1mM EDTA, 20 mM Tris-succcinate, pH 7.5 at 4°C.  The 
suspended cells were centrifuged at 22,000 x g for 25 using Beckman J2-HS centrifuge 
and JA14 rotor to wash off the medium. The supernatant was discarded and the celles 
were weighed, and stored at -20°C. About 5-6 grams of cells were routinely obtained 
from 1 liter of culture. 





       
tetracycline, 1 µg/ml; and trimethoprim, 30 µg/ml. 
 
Escherichia coli 
 The cells were grown aerobically at 37°C in LB medium. Antibiotics, when 
needed, were added at the following concentrations: ampicillin, 125 µg/ml; kanamycin 




Construction of Expression Plasmid and Site-Directed Mutagenesis 
 
 
Construction of an R. sphaeroides Strain Expressing the His6- 
Tagged Cytochrome bc1 Complex 
 
 
The expression vector for His-tagged four-subunit cytochrome bc1 complex 
(pRKD418fbcFBKmBPC6HQ) was constructed.  
(1) Construction of pRKDfbcFBKmBPCQ (pRKDNB35KmBP) (2). 
 The gene encoding a trimethoprim-resistant dihydrofolate reductase from R388 
(3) (excised from pSup5Tp) and the engineered fbc-containing insert from pSELNB3503 
(2) were combined into the multiple cloning site polylinker of pSL1180 by a series of in 
vitro manipulations.  The resulting 4,400-base pair fragment containing the dihydrofolate 
reductase gene and the R. sphaeroides fbc operon were subcloned together into the 
HindIII and EcoRI sites of the vector pRK415 (4), producing pRKDNB3503.  For the 





       
following mutagenesis, pRKDNB35KmBP was constructed by inserting the kanamycin 
resistance cassette from pUC4K between the BstEII and PinAI sites of pRKDNB3503. 
Using pRKDNB3503KmBP to receive the mutated BstEII-PinAI fragments eliminates 
the possibility of retaining or recloning the wild-type fragment when attempting to  
subclone the mutated fragments into the expression vector (5).  Loss of kanamycin 
resistance was then used to screen for recombinant plasmids. 
(2) Construction of pRKDfbcFBC6HQ (6).  
A 1,200-base pair XbaI-HindIII fragment containing the fbcC and fbcQ genes 
from pRKDfbcFBCQ (2), containing fbcF, fbcB, fbcC, and fbcQ, was inserted into a 
modified pSELECT-1 vector in which the unique Acc65I site was eliminated.  The 
resulting pSELfbcCQ was used as template for site-directed mutagenesis to introduce an 
Acc65I recognition site right before the stop codon of the fbcC gene.  Two comple-
mentary oligonucleotides with His6 tag coding sequence and the Acc65I overhang 
attached at the 5’-ends (5’-GTACGGGC CAT CAC CAC CAC CAT CAC TAA-3’ and 
3’-CCCG GTA GTG GTG GTG GTA GTG ATTCATG-5’) were synthesized, annealed 
together by heating up to 70°C and cooling slowly to room temperature, and ligated into 
the Acc65I site of pSELfbcCQ to generate pSELfbcC6HQ.  The 6-histidine insertion was 
confirmed by DNA sequencing.  A 1,200-base pair XbaI-HindIII fragment containing 
fbcC6HQ from pSELfbcC6HQ was subcloned into an expression vector (pRKDNB3503) 
containing the fbcFBCQ genes to generate pRKDfbcFBC6HQ.  pRKDfbcFBC6HQ was 
transformed into E. coli S-17, and then mobilized into R. sphaeroides BC17 by using a 
plate-mating procedure (2).  R. sphaeroides BC17 is a strain from which most of the 





       
(3) Construction of pRKD418fbcFBKmBPC6HQ.  
A 4,887 base pair EcoRI-HindIII fragment containing fbcF, fbcB, fbcC, and fbcQ, 
was inserted into pRKD418 vector which contains an additional resistance gene and an 
enlarged multiple cloning site region (8).  The resulting 16,587 base pair pRKD418 
fbcFBC6HQ plasmid was digested by EcoRI and XbaI to get 13,207 base pair fragment 
containing fbcC with 6-Histidine at the C-terminal and fbcQ.  The plasmid 
pRKDfbcFBKmBPCQ was also digested with EcoRI and XbaI to get the 4,632 base pair 
fragment containing fbcF, fbcB with kanamycin resistance cassette inserted between the 
BstEII and PinAI sites.  Then a 13,207 base pair fragment was ligated with a 4,632 base 
pair fragment to get pRKD418fbcFBKmBPC6HQ plasmid.  Loss of kanamycin resistance 




Site-Directed Mutagenesis on Cytochrome b with QuickChange 
 
 
 A 3,380 base pair EcoRI-XbaI fragment containing the fbcF and fbcB genes from 
pRKDfbcFBCQ, containing fbcF, fbcB, fbcC, and fbcQ, was inserted into a pGEM7Zf(+) 
vector from Promega.  The resulting pGEM7Zf(+)fbcFB was used as the template  and 
two synthetic oligonucleotides containing desired mutation were used as primers for site-
directed mutagenesis.  All template and primers are listed in Table 1.  
 The mutagenic oligonucleotides primers used with QuickChange system must be 





       
 
 
Table 1. Mutations of Cytochrome b 
 
  Mutamts Mutagenesis  
method 
Template  primer 
cytb∆(421–445) QuickChange pGEMa
   
fb:CGAGAAGCCGGTGGCTCCGTA
AGCGACCATCGAAGAAGc
   rd: CTTCTTCGATGGTCGCTTACG 
GAGCCACCGGCTTCTCG 




   GGTCGCGGGCGG 




   TCTTCGATGGTCGCGGG 
cytb∆(433–445) QuickChange pGEM  f:CAACGCCCACTACTAA 
   CCGGCGACCGGCGG 
   r:CCGCCGGTCGCCGGTTA    GTAGTGGGCGTTG 
   
a, pGEM7Z(+)fbcFB 
b, forward primer 
c, all primers are listed from 5’ end to 3’ end 





       
 
1. Both mutagenic primers must contain the desired mutation and anneal to the same 
sequence on opposite strands of the plasmid. 
2. Primers should be between 25 and 45 bases in length, and the melting temperature 
(Tm) of the primers should be greater than or equal to 78°C. The following 
formula is commonly used for estimating the Tm of primers: 
           Tm = 81.5 + 0.41 x (%GC) - 675/N -  %mismatch (N is the primer length in bases).  
3. The desired mutation should be in the middle of the primer with ~10-15 bases of 
correct sequence on both sides. 
4.   The primers optimally should have a minimum GC content of 40% and should 
terminate in one or more C or G bases. 
The sample reactions were prepared as indicated below: 
5 µl of 10 x reaction buffer 
20 ng of double strand DNA template 
125 ng of oligonucleotide primer #1 
125 ng of oligonucleotide primer #2 
1 µl of dNTP mix (10mM, from Promega) 
ddH2O to a final volume of 50 µl 
Then add 1 µl of PfuTurbo DNA polymerase (2.5 U/µl, from Stratagene®) 
Then overlay each reaction with ~30 µl of mineral oil. 
The thermal cycle was set up in a MiniCyclerTM from M. J. Research as follows: 
Step 1: 95°C 2 minutes for initiation; 
Step 2: 95°C 50 seconds for denaturation; 





       
Step 4: 72°C 7 minutes for extension reaction; 
Step 5: Step 2 to Step 4 were repeated 18 times 
Step 6: 72°C 7 minutes 
The amplification can be checked by electrophoresis of 10 µl of the product on a 
1% agarose gel.  A ~6,000 base pair band should be clearly visualized at this stage. 
Following the thermal cycle, the amplification product was treated with the 
restriction enzyme DpnI (from Promega, 1 µl each time, two times).  The DpnI 
endonuclease is specific for hemimethylated and methylated DNA, therefore, this 
digestion is used to select mutation-containing synthesized DNA, since DNA isolated 
from most of E.coli stains are dam methylated at adenine residues in the sequence 
5’…GmATC…3’ and susceptible to DpnI digestion, while the in vitro synthesized DNA is 
not. The DpnI treated product was then transformed into XL1-Blue competent cells. 
Plasmid purified from a single XL1-Blue colony was digested with EcoRI and XbaI, ran 
the 1% agarose gel to check the size, if the size of the plasmid was correct, this plasmid 
was sequenced to confirm the mutation.  
The pGEM7Z(+)fbcFB plasmid with the mutation (pGEM7Z(+)fbcFBm) was 
digested with BstEII and XbaI (BstEII /XbaI) or EcoRI and XbaI (EcoRI /XbaI) to get 
961bp or 3379bp insert, respectively.  The pRKD418fbcFBKmBPC6HQ plasmid also 
digested with BstEII and XbaI (BstEII /XbaI) or EcoRI and XbaI (EcoRI /XbaI) to get 
15,626 base pair or 13,208 base pair vector.  Then the insert was ligated into the 
respective vector to get the pRKD418/fbcFBmC6HQ plasmid.  Loss of kanamycin 
resistance was used to screen for recombinant plasmids containing the mutant 





       
The pRKD418/fbcFBmCHQ plasmid in E. coli S17-1 cells was mobilized 
into R. sphaeroides BC-17 cells by a plate-mating procedure (2).  The presence of 
engineered mutations was confirmed twice by DNA sequencing of the 962 base pair 
BstEII-XbaI fragment before and after photosynthetic growth.  
 
 
Protein Purification of Histidine-Tagged Cytochrome bc1 Complex 
 
 Frozen R. sphaeroides cell (wild-type or mutated) was suspended in 20 mM Tris-
succinate, 1 mM EDTA (3 ml/g of cells) and passed through French Press with at about 
1000 psig with 1’’ diameter piston to break the cell.  Protease inhibitor 
phenylmethanesulfonyl fluoride (PMSF), which was prepared routinely as 1 M in 
dimethyl sulfoxide (DMSO), was added to the cell suspension to a final concentration of 
1mM before passing through the French Press, and was added to the same concentration 
one more time after the first time passage through the French Press.   
 The broken cells were centrifuged at 40,000 x g (19,000 rpm) with the Beckman 
J2-HS centrifuge and JA20 rotor for 20 minutes to get rid of the unbroken cell and cell 
debris. The supernatant was then subjected to centrifugation at 220,000 x g (54,500 rpm 
with Ti70 rotor) for 150 minutes to separate the chromatophore fraction from the soluble 
protein fraction.  The precipitate obtained was suspended with 50 mM Tris-Cl, pH 7.5 
(room temperature), 1 mM MgSO4 containing 1 mM PMSF, and then homogenized. The 
homogenate was then subjected to centrifugation at 220,000 x g (54,500 rpm with Ti70 
rotor) for 90 minutes to recover chromatophore in precipitate.  The resulting 





       
MgSO4, 20% glycerol with final volume about 1 ml per 1g cell, and stored at -80°C. 
 To purify the His-tagged cytochrome bc1 complex, the frozen chromatophore was 
thawed and adjusted to a cytochrome b concentration of 25 µM with 50 mM Tris-Cl, pH 
7.5 (room temperature), 1 mM MgSO4.  10% of  dodecylmaltoside (DM) solution (w/v) 
was added drop by drop to the chromatophore suspension to 0.56 mg/nmol of cytochrome 
b, 4 M NaCl was also added to the final concentration of 100 mM. Then the mixture was 
stirred at 4°C for 1 hour and then centrifuged at 220,000 x g (54,500 rpm with Ti70 rotor) 
for 90 minutes. The supernatant was collected and passed through a Ni-NTA agarose 
column (about 1ml bed volume for every 100nmol of cytochrome b in the chromatophore 
suspensinon), equilibrated with 50 mM Tris-Cl, pH7.5 (room temperature) containing 1 
mM MgSO4.  The column, absorbed with bc1 complexes, was then subjected to a 
sequence of washing with (1) 4 volume of 50 mM Tris-Cl pH8.0 (4°C), 200 mM NaCl, 
0.01%DM;  (2) 4 volume of 50 mM Tris-Cl pH8.0 (4°C), 200mM NaCl, 5mM Histidine, 
0.01%DM; (3) 2 volume of 50mM Tris-Cl pH8.0 (4°C), 200mM NaCl, 0.5% octyl 
glucoside (OG).  The pure cytochrome bc1 complex was eluted with 50 mM Tris-Cl 
pH8.0 (4°C), 200 mM NaCl, 200 mM Histidine, 0.5% OG, and concentrated to a final 
concentration of 300 µM or higher by using a Centriprep concentrator with a 30 KDa or 
50 kDa cut-off. The purified complex was stored at -80°C in the presence of 20% 
glycerol.  
 
Determination of Cytochrome Content 
 
Absorption spectra were recorded at room temperature in a Shimadzu UV2101 





       
10 mM potassium ferricyanide.  The cytochrome c1 was reduced by adding a few crystals 
of sodium ascorbate, and the content of cytochrome c1 was determined from the sodium 
ascorbate reduced minus potassium ferricyanide difference spectrum using the extinction 
coefficient of 17.5 cm-1mM-1 for wavelength pair 552 and 540 nm (10). The cytochrome 
b was reduced by adding a few crystals of sodium dithionite.  The content of cytochrome 
b was determined from the sodium dithionite reduced minus potassium ferricyanide 
difference spectrum using the extinction coefficient of 28.5 cm-1mM-1 for wavelength 
pair 560 and 576 nm (11).  
  
 
Enzymatic Activity Assay 
 
Chromatophores or purified cytochrome bc1 complexes were diluted with 50 mM 
Tris-Cl, pH 8.0 (4°C), containing 200 mM NaCl and 0.01% dodecyl-maltoside to a final 
concentration of cytochrome b of 3 µM. Appropriate amounts of the diluted samples were 
added to 1 ml of assay mixture containing 100 mM Na+/K+ phosphate buffer, pH 7.4, 1 
mM EDTA, 100 µM cytochrome c (from horse heart, Sigma), and 25 µM Q0C10BrH2. 
Ubiquinol cytochrome c reductase activity of R. sphaeroides bc1 complex was 
determined by measuring the reduction of cytochrome c by following the increase of 
absorbance at 550 nm in a Shimadzu UV 2101 PC spectrophotometer at 23 °C, using a 
millimolar extinction coefficient of 18.5 cm-1 for calculation. The nonenzymatic 
oxidation of Q0C10BrH2, determined under the same conditions, in the absence of enzyme, 
was subtracted.  Although the chemical properties of Q0C10BrH2 are comparable with 





       
measure bc1 activity in chromatophore, 30 µM potassium cyanide was added to the assay 





Different amounts of dodecyl maltoside were added into 1 ml aliquots of 
chromatophore prepared from wild type and mutants cells containing 50 µM cytochrome 
b in 50 mM Tris-Cl, pH8.0 (4°C), 1 mM MgSO4. After incubating at 0 °C for 1 h, 
appropriate aliquots were withdrawn from each sample and assayed for ubiquinol-
cytochrome c reductase activity using a 3 ml assay mixture containing100 mM Na+/ K+ 
phosphate buffer, pH 7.4, 1 mM EDTA, 100 µM cytochrome c (from horse heart, Sigma), 
and 25 µM Q0C10BrH2.  The assay method is the same as the one described in Enzymatic 
Activity Assay section. The rest of the samples were subjected to centrifugation at 20,000 
x g (75,000 rpm) in Beckman OptimaTM TL-100 Ultracentrifuge with TLA 100.4 rotor for 
90 min. The cytochrome b content in supernatant fractions was determined as mentioned 
above. The 100% cytochrome b content refers to that in the dodecyl maltoside-treated 
sample before centrifugation.  The unit of specific activity is µmol of cytochrome c 
reduced/min/nmol of cytochrome b. 
 
SDS-Polyacrylamide Gel Electrophoresis 
 
Analytical SDS-polyacrylamide gel electrophoresis was performed using a Bio-





       
Table 2. Purified wild type and mutants bc1 complex (50 pmol of cytochrome c1) were 
digested in the sample buffer (0.0635 M Tris-CL, pH6.8, 2% SDS, 5% β-mercaptoethanol, 
0.002% Bromophenol Blue and 10% glycerol) at 37°C for 30 minutes.  Then the samples 




After SDS-PAGE was done, the gel was equilibrated with transfer buffer (25 mM 
Tris, 192 mM glycine, 20% v/v methanol) at room temperature for 20 min with gentle 
shaking.   This procedure was repeated three times.  The polypeptides separated in the 
SDS-PAGE gel were transferred to a 0.22 µm nitrocellulose membrane by using Trans-
Blot®SD Semi-Dry Transfer cell from BIO-RAD for 30 minutes, and the voltage used 
was 15V.   The membrane was now ready for the immunoblotting assay. 
The procedure of immunoblotting assay was as the following: 
1) After electophoretic blotting was done, the membrane was immersed in TBS 
buffer (20 mM Tris, 500 mM NaCl, pH7.5) for 10 minutes, face up; 
2) The TBS solution was discarded and replaced with blocking solution (3% 
gelatin, 20 mM Tris, 500 mM NaCl, pH7.5), and gently agitated for one hour 
at room temperature; 
3) The blocking solution was discarded and replaced with TTBS buffer (0.05% 
Tween-20, 20 mM Tris, 500 mM NaCl), and gently agitated at room 
temperature for 5 minutes.  The membrane was washed using TTBS buffer 





       
4) The TTBS solution was discarded and replaced with the first antibody 
solution (1% gelatin, 20 mM Tris, 500 mM NaCl, pH7.5, and the diluted 
rabbit polyclonal antibodies raised against purified ISP and subunit IV), and 
gently agitated overnight at room temperature. 
5) The first antibody solution was discarded and replaced with TTBS, and gently 
agitated for 5 minutes at room temperature.  The membrane was washed using 
TTBS buffer one more time; 
6) The TTBS solution was discarded and replaced with Protein A horseradish 
peroxidase conjugate from Bio-rad (second antibody), and gently agitated for 
one hour at room temperature; 
7) The second antibody solution was discarded and replaced with TTBS, and 
gently agitated for 5 minutes. The membrane was washed using TTBS buffer 
one more time; 
8) The TTBS solution was discarded and replaced with TBS solution, gently 
agitated for 5 minutes at room temperature. The membrane was washed using 
TBS buffer one more time; 
9)   The TBS solution was discarded and added HRP color development solution 
prepared freshly ([a]. Dissolve 30 mg HRP Color Development Reagent from 
Bio-rad in 10 ml ice cold methanol, [b]. Immediately prior to use, add 30 µl of 
ice cold 30% H2O2 to 50 ml room temperature TBS, [c]. Mix [a] with [b] right 
before use.).  During color development, the chamber which the membrane 
was soaked in the solution should be wrapped with aluminum foil. Gently 





       
  
 
Table 2. SDS-PAGE gel preparation and running condition 
   Staking gel Separating gel Running conditions 
1.5M Tris-Cl, pH 8.0 1 ml 2.5 ml 
deionized H2O 2.3 ml 3.2 ml 
30% acrylamide:Bis 0.63 ml 4.17 ml 
10% SDS 40 µl 0.1 ml 




TEMED 5 µl 5 µl 
Running buffer: 3.028% (w/v) 
 Tris, 14.412% (w/v) 
glycine,  
1% (w/v) SDS; 
 
200V for 45 minutes 
Acrylamide 0.24 g 1.6 g 
Bis-acrylamide 0.0075 g 0.07 g 
Gel buffer 1.5 ml 3.34 ml 
Urea 0 4.2 g 
Total volume 3 ml 10 ml 








TEMED 5 µl 5 µl 
 
 
Running buffer: anode buffer: 
0.2 M Tris, pH 8.9; 
cathode buffer: 
0.1 M Tris, 
0.1M Tricine,  
0.1% SDS; 
 




APS: Ammonium persulfate; 
Gel buffer: 3 M Tris, 1 M HCl, 0.3 % SDS; 
T: the total concentration of acrylamide and bisacrylamide; 








       
     10)  The HRP color development solution was discarded and replace with distilled      
water, gently agitated for 10 minutes and changed to the deionized water at 
least once. 
11) The membrane was stored at dark. 
 
 
Potentiometric Titration  
 
Redox titrations of cytochromes b and c1 in complement and mutant bc1 
complexes were essentially according to the previously published method (14,15). 3 ml 
of aliquots of the bc1 complex (2 µM cytochrome b or 2 µM cytochrome c1) in 0.1 M 
Na+/K+ phosphate buffer, pH 7.0, containing 20 µM phenazine methosulfate (midpoint 
redox potential (Em +80 mV), 20 µM phenazine ethosulfate (Em +55 mV), 20 µM 
phenazine (Em -120 mV), 20 µM pyocyanine (Em -34 mV), 25 µM 1,4-benzoquinone 
(Em +293 mV), 25 µM 1,2-naphthoquinone (Em +143 mV), 25 µM 1,4-naphthoquinone 
(Em +36 mV), 50 µM duroquineone (Em +5 mV), 70 µM 2,3,5,6-tetramethyl-p- 
phenylenediamine (Em +260 mV), and 15 µM 2-hydroxy-1,4-naphthoquinone 
(Em -145 mV), were used.  Reductive titrations were carried out by addition of sodium 
dithionite solution to the ferricyanide-oxidized sample; oxidative titrations were carried 
out by addition of ferricyanide solution to the dithionite-reduced sample.  At indicated Eh 
values during the redox titration, absorption spectra from 600 to 500 nm were taken with 
a Shimadzu model UV-2100 spectrophotometer.  The absorbance at 562 nm, minus that at 





       
midpoint potentials of cytochrome bL and bH were calculated by fitting the redox titration 
data, obtained for cytochrome b, the Nernst equation for a one-electron carrier  
(n =1) with two components using the KaleidaGraph 3.5 program, and that of cytochrome 
c1 was fitted for a one-electron carrier with one component.  
 
 
Electron Paramagnetic Resonance Spectrometry 
 
EPR spectra were recorded with a Bruker EMX spectrometer, equipped with a 
liquid helium flow cryostat, at 7 K.  Purified wild-type and mutant bc1 complexes (230 
µM cytochrome b) were treated with a small excess of ascorbate solution to fully reduce 
cytochrome c1 and frozen in liquid nitrogen immediately.  EPR spectra of the [2Fe-2S] 
cluster of the Rieske iron-sulfur protein were obtained from samples scanning once 
from 3200 to 4000 G magnetic field. In order to get the gy signal amplitude in mutant 
complexes about the same as that in the wild type complex, different scanning times were 
applied.  EPR spectra were recorded with the following instrument settings: microwave 
frequency, 9.3 GHz; microwave power, 2.2 milliwatts; modulation amplitudes, 6.3 G; 
modulation frequency, 100 kHz; time constant, 665.4 ms; sweep time: 167.8 s; 
conversion time, 163.8 ms.  Sample preparation and instrument settings of EPR spectra of 
cytochrome bL and bH were the same as those for the [2Fe-2S] cluster of the Rieske iron-
sulfur protein, except that the microwave power used was 108.1 milliwatts and 







       
 
Saturation Transfer EPR (ST EPR) Measurement 
 
  EPR measurements were made with a Bruker EMX EPR spectrometer, using an 
aqueous quartz flat cell.  The temperature of the microwave cavity was controlled by 
circulation of cooled nitrogen gas from a modified variable temperature housing 
assembly equipped with an electric temperature sensor.  The instrument settings were as 
follows: field modulation frequency, 100kHz; microwave power, 107.8 mW; time 
constant, 1310.72 ms, modulation amplitute, 8 G; microwave frequency, 9.757 GHz, 
which were employed with phase-sensitive detection at 100 Hz (second harmonic) 900 
out of phase.  The phase was adjusted to minimize the second harmonic signal. 
Approximate rotational correlation time (τ2) was obtained from the ratio of the two field 
lines (L”/L).  
 
 
Mass Spectrometry Determination 
 
The mass spectrometry determination of molecular weights of cytochrome 
b in the wild type and mutant bc1 complexes was performed with an Applied Biosystems 
DE-PRO MALDI-TOF mass spectrometer operated in delayed-extraction positive-ion 
liner mode according to the method of Ghaim et al. (16) with modifications.  Samples 
(~30 µl) were mixed with 6 volumes of 10% trichloroacetic acid, chilled for 5 min on ice, 
centrifuged, and the precipitate was rinsed briefly with 95% ethanol to remove salts.  The 





       
formic acid to a final volume of 60 µl, which gave the best crystals and signal.  As matrix 
for MALDITOF analyses, 1% of 2,5-dihydroxybenzoic acid in 30% acetonitrile, 0.1% 
trifluoroacetic acid and 1% 5-methoxysalicilic acid in 30% acetonitrile, 0.1% 
trifluoroacetic acid were mixed 9:1 (v/v).  This matrix solution was mixed 1:1 (v/v) with 
protein samples.  Matrix and sample were spotted onto the sample plate, and were 




Differential Scanning Calorimetry (DSC) 
 
 Differential scanning calorimetric measurements were performed with a CSC 
6100 NanoII DSC instrument.  The bc1 sample was diluted in phosphate buffer (Na/K Pi 
100mM, pH 7.4) instead of Tris buffer to avoid the large pH change during the heating. 
Prior to being loaded in the “sample cell” of the machine. 0.50 ml sample of bc1 solution, 
2 mg/ml, in 50 mM K+/Na+ phosphate buffer, pH7.4, containing 100mM KCl and 0.5% 
octyl glucoside was degassed for 5 min to remove dissolved air, which may interfere with 
the DSC data during the heating process.  The same volume of buffer was loaded into the 
“reference cell” of the instrument, after being degassed.  During the scanning, both the 
sample and the buffer were heated from 10°C to 90°C, cooled back to 10°C and heated  
again to 90°C, with the scanning rate of 1°C/min for both heating and cooling.  The cells 
were equilibrated at 10°C and 90°C for 10 min before heating and cooling.  The 
difference of power input between the “sample cell” and the “reference cell” was 





       
cells were done at a steady rate of 1°C per minute.  The second heating scan was used as 
the baseline. Melting temperature (Tm) and enthalpy change (∆H) of the sample were 
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The Role of Extra Fragment at the C-terminal of Cytochrome b 





The cytochrome bc1 complex is an essential energy transduction electron transfer 
complex in mitochondria and many aerobic and photosynthetic bacteria (1).  The 
complex catalyzes electron transfer from ubiquinol to cytochrome c1 with concomitant 
translocation of protons across the membrane to generate a membrane potential and 
proton gradient for ATP synthesis.  All the cytochrome bc1 complexes contain three core 
subunits, cytochrome b, cytochrome c1, and Rieske iron-sulfur protein (ISP), which house 
two b-type hemes (bL and bH), one c-type heme (heme c1), and a high potential [2Fe-2S] 
cluster, respectively.  In addition to these three core subunits, the cytochrome bc1 
complex also contains varying numbers (one to eight) of non-redox containing subunits, 
known as supernumerary subunits (2,3).  
Because the bacterial complexes contain no (or one) supernumerary subunit, it is 
unlikely that the structures of the core subunits in these complexes are, as suggested for 
the mitochondrial complex (4), stabilized through interactions between core subunits and 





       
subunit and another part of the same subunit or another core subunit contribute to the 
stability of a core subunit in the bacterial complex.  This speculation finds some support 
from the fact that core subunits in bacterial complexes are generally bigger than their 
counterparts in the mitochondrial complex. 
Sequence alignment of cytochrome b, cytochrome c1, and ISP in bacterial 
complexes with their counterparts in mitochondrial complexes reveals four extra 
fragments in bacterial cytochrome b and one each in bacterial cytochrome c1 and ISP (5). 
These extra fragments are modeled into the structure of the Rhodobacter sphaeroides bc1 
complex by using coordinates of mitochondrial supernumerary subunits (5).  These 
findings encouraged us to suggest that these extra fragments may possess mitochondrial 
supernumerary subunit function in stabilizing the structure of the core subunits in the 
bacterial complex.  This suggestion is further supported by the recent finding that ISP is 
lost from the R. sphaeroides bc1 complex if the extra fragment of ISP is deleted or 
substituted with alanine (6).  Of course, confirmation of this suggestion will have to wait 
until the function of extra fragments in cytochrome b and c1 are established.  
Cytochrome b holds a central role in the cytochrome bc1 complex because it 
houses two ubiquinone binding sites, Qo and Qi, and two redox centers, heme bL and 
heme bH.  According to the Q-cycle mechanism (7), electrons from ubiquinol are 
bifurcated at the Qo site.  The first electron of ubiquinol is transferred through the so-
called “high potential” chain consisting of [2Fe-2S] and heme c1.  The second electron of 
ubiquinol is passed through the “low potential” chain consisting of hemes bL and bH. 
Thus, maintaining the structural stability of cytochrome b in the bc1 complex is crucial 





       
In the structure model of R. sphaeroides cytochrome bc1 complex (5), the four 
extra fragments of cytochrome b are located at the N terminus (residues 2 to 12), the 
connecting loop between helices D and E (residues 232 to 239), the connecting loop 
between helices E and F (residues 309 to 326), and the C terminus (residues 421–445) 
(see Fig. 1).  We started functional studies of these cytochrome b extra fragments with the 
one at the C terminus because this extra fragment is in close proximity to subunit IV and 
ISP.  Herein we report generation of R. sphaeroides mutants expressing His-tagged 
cytochrome bc1 complexes with progressive deletion of the C-terminal extra fragment of 
cytochrome b.  The photosynthetic growth behavior, the bc1 activity, and the amount of 
cytochrome b, cytochrome c1, ISP, and subunit IV, in the chromatophore membrane and 
the purified state, of the complement and mutants, were determined and compared.  The 
lability of mutant bc1 complex, in the chromatophore membranes, toward 
dodecylmaltoside treatment, was investigated.  The effect of mutations on EPR spectra of 
the cytochromes b and ISP and on redox potentials of the cytochromes b and c1, in 
complement and mutant complexes, is also reported. 
 
Results and Discussion 
 
 
Comparison of Electron Transfer Activity, Subunit Composition, and Detergent Lability 
of Cytochrome bc1 Complexes in Chromatophore Membranes from Complement and C-
terminal Truncated Cytochrome b Mutants 
 
The C-terminal extra fragment of R. sphaeroides cytochrome b corresponds to 










Fig.17. Location of the C-terminal extra fragment of cytochrome b in the proposed 
structural model of R. sphaeroides cytochrome bc1 complex.  One monomer (left) is 
displayed in solid ribbons, and the symmetric monomer (right) is displayed in three-
treadline ribbons.  Cytochrome c1 is rust; ISP is brown; subunit IV is silver; cytochrome 












  Fig.18. Partial sequence comparison in the C-terminal extra fragment of various 
    cytochrome b.  The abbreviations used are: Rs, R. sphaeroides; Rc, R. capsulatus;  











       
18).  To probe the role of this fragment, R. sphaeroides mutants with progressive deletion 
of amino acid residues from the C terminus of cytochrome b were generated and 
characterized.  These are: cytb∆(433–445), cytb∆(427–445), cytb∆(425–445), and 
cytb∆(421–445) with deletion of 13, 19, 21, and all residues from this C-terminal extra 
fragment of cytochrome b, respectively.  
When these four C-terminal-truncated cytochrome b mutants were subjected to 
anaerobic photosynthetic growth conditions, all of them grew at a rate comparable with 
that of the complement cells.  Chromatophores prepared from these mutant cells have the 
content and absorption spectral properties of cytochrome b and cytochrome c1 + c2 
similar to those in the complement chromatophores (data not shown). The amounts of ISP 
and subunit IV in these mutant chromatophores, determined by Western blotting using 
antibodies against R. sphaeroides ISP and subunit IV, respectively, are also comparable 
with those in complement chromatophores.  These results indicate that the C-terminal 
extra fragment of cytochrome b is not required for assembly of the cytochrome bc1 
complex protein subunits (cytochromes b and c1, ISP, and subunit IV) into the 
chromatophore membrane. 
Fig. 19A shows the effect of DM concentration on bc1 activity in the complement 
and four mutant chromatophores.  When chromatophores from the complement and four 
mutants, at a cytochrome b concentration of 25 µM, were treated with varying 
concentrations of DM (up to 0.64 mg of DM per nmol of cytochrome b), bc1 activities in 
all preparations increase at lower and decrease at higher detergent concentrations. 
However, the detergent concentrations required for maximum activity increasing and 









Fig.19. Effect of DM concentration on bc1 activity and solubilization of cytochrome b 
from complement and mutant chromatophores.  1-ml aliquots of chromatophore 
preparations from complement (o), and mutants cytb∆-(433-445) (x), cytb∆-(427-445) 
(∆), cytb∆-(425-445) ( ), and cytb∆-(421-445) (•), containing 50 µM cytochrome b, 
were added at the indicated amounts of DM.  After incubating at 0°C for 1 hr, appropriate 
aliquots were withdrawn from each sample and assayed for ubiquinol-cytochrome c 
reductase activity using a 3-ml assay mixture (A).  The rest of samples were subjected to 
centrifugation at 100,000 x g for 90 min.  The cytochrome b content in supernatant 
fractions was determined (B).  The 100% cytochrome b content refers to that in the DM-
treated sample before centrifugation.  The unit of specific activity is µmol of cytochrome 






       
detergent concentration varies greatly among these chromatophores.  
Mutant chromatophores of cytb∆(433–445), cytb∆(427–445), cytb∆(425–445) 
and cytb∆(421–445), without DM treatment, have, respectively, 100, 82, 70, and 62% of 
the bc1 activity found in untreated complement chromatophores.  Maximum bc1 activities 
are obtained for mutant chromatophores of cytb∆(433–445), cytb∆(427–445), 
cytb∆(425–445), and cytb∆(421–445) at DM concentrations of 0.35, 0.25, 0.15, and 0.08 
mg/nmol of cytochrome b, respectively.  These correspond, respectively, to 95, 83, 77, 
and 56% of maximum bc1 activity of the complement chromatophores treated with 0.35 
mg of DM per nmol of cytochrome b (see Fig. 19A).  Thus the bc1 complexes with 
decreasing lengths of the C-terminal extra fragment of cytochrome b require decreasing 
amounts of DM to obtain maximum activity.  Furthermore, maximum bc1 activity in the 
chromatophore membrane decreases as the C-terminal extra fragment of cytochrome b 
shortens. 
Whereas the complement chromatophores treated with 0.35 mg of DM/nmol of 
cytochrome b shows maximum bc1 activity, mutant chromatophores of cytb∆(433–445), 
cytb∆(427–445), cytb∆(425–445), and cytb∆(421–445) treated with the same 
concentration of DM lost, respectively, 0, 22, 35, and 81% of their maximum bc1 activity, 
indicating that the lability of the bc1 complex toward detergent treatment increases as the 
size of the C-terminal extra fragment decreases.  The increase in lability of the bc1 
complex to detergent treatment should be indicative of a decrease in structural stability of 
the complex.  Thus, the structural stability of the bc1 complex decreases as the C-terminal 
extra fragment of cytochrome b decreases.  Residues 433–445 make little contribution to 





       
lability of the cytb∆(433–445) bc1 are similar to those of the complement complex. 
It should be noted that the effectiveness of DM in solubilizing the bc1 complex 
from these deletion mutant chromatophores is comparable with that for the complement 
chromatophores (Fig.19B).  When complement and mutant chromatophores of  
cytb∆(433–445), cytb∆(427–445), cytb∆(425–445), and cytb∆(421–445) treated with 
various concentrations of DM were centrifuged at 200,000 x g for 90 min, the contents of 
cytochrome b, determined spectrophotometrically (see Fig. 19B), ISP, and subunit 
IV determined by Western blotting (data not shown), in the supernatant fractions, at a 
given DM concentration, are about the same.  This suggests that the loss of bc1 activity in 
the cytb∆(421–445) mutant chromatophores treated with 0.35 mg of DM/nmol of 
cytochrome b is not because of a decrease of binding affinity of the bc1 complex to the 




Effect of the C-terminal Extra Fragment of Cytochrome b on 
the Binding of Cytochrome b, ISP, and Subunit IV to Cytochrome c1
 
To further confirm that the structural integrity of the bc1 complex decreases as the 
C-terminal extra fragment of cytochrome b decreases, binding affinities of protein 
subunits in mutant complexes of cytb∆(433–445), cytb∆(427–445), cytb∆(425–445), and 
cytb∆(421–445) were determined and compared with those of the complement complex. 
Because the expressed R. sphaeroides bc1 complex has a His6 tag at the C terminus of 





       
to cytochrome c1 in complement and mutant complexes using a Ni-NTA column. 
When various chromatophores were treated with 1.2% DM and centrifuged at 
200,000 x g for 90 min, about 80% of cytochrome b, cytochrome c1, ISP, and subunit IV 
in the complement and mutant chromatophores was recovered in the supernatant fractions. 
When these supernatant fractions were applied to Ni-NTA columns, most of cytochrome 
c1 in all of these supernatant fractions as absorbed on the Ni-NTA gel, and as recovered in 
column eluates using an eluting buffer containing 200 mM histidine.  This is as expected 
because the His6 tag is placed at the C terminus of cytochrome c1.   The b/c1 ratios in 
column eluates of the complement and mutants cytb∆(433–445), cytb∆(427–445), 
cytb∆(425–445), and cytb∆(421–445) are 1.51, 1.45, 0.81, 0.72, and 0.29, respectively 
(see Table 3), indicating that the binding affinity of cytochrome b to cytochrome c1 
decreases as the C-terminal extra fragment of cytochrome b shortens.  The amount of 
mutant cytochrome b of cytb∆(433–445), cytb∆(427–445), cytb∆(425–445), and 
cytb∆(421–445) associated with cytochrome c1, as compared with the amount of wild-
type cytochrome b associated with cytochrome c1, decreases by 4, 46, 52, and 80%, 
respectively.  
Fig.20. shows Western blot analysis of ISP and subunit IV recovered in the Ni-
NTA column eluate (purified bc1 complex) and effluent fractions from DM-solubilized 
complement and mutant chromatophores.  The purified cytb∆(421–445) mutant complex 
contains no detectable ISP or subunit IV, however, purified mutant complexes of 
cytb∆(425–445), cytb∆(427–445), and cytb∆(433–445) have 50, 80, and 100%, 






       
 
 
Table 3. Characterization of mutants having deletions on the C-terminal 
extra fragment of  cytochrome b 
 
Cytochrome bc1 complex 
                    Chromatophore Purified complex 
 
     Strains                  Psa
specific         cytb/          subunit 
activityb       cytc1+c2    composition 
   specific 
activityb
cytb/cytc1               subunit 
   composition 
  complement           +++c 2.24          1.26             FBCQd 3.20        1.51           FBCQ 
cytb∆(433-45)         +++ 2.23          1.30             FBCQ 2.91        1.45           FBCQ 
cytb∆(427-45)         +++      1.87          1.39             FBCQ      2.88         0.81           FBCQ 
cytb∆(425-45)         +++ 1.52          1.35             FBCQ 1.69         0.72           FBCQ 
cytb∆(421-45)         +++ 1.32          1.23             FBCQ    0              0.29           FB 
 
aPs: photosynthetic growth.  benzyme activity is expressed as µmol cytochrome c 
reduced/min/nmol cytochrome b.  c+++ indicates the cells can grow photosynthetically 
and the growth rate was essentially the same as that of the complement cells.  dFBCQ 
indicates gene products of the fbcF (ISP) (F),  fbcB(cytochrome b) (B), fbcC (cytochrome 











       
 
Fig.20. Western blot analysis of ISP and subunit IV in the Ni-NTA column effluent and 
eluate fractions from DM-solubilized complement and mutant chromatophores.  2-ml of 
DM-solubilized complement (lane 2) and mutant chromatophores of cytb∆(433–445) 
(lane 3), cytb∆(427–445) (lane 4), cytb∆(425–445) (lane 5), and cytb∆(421–445) (lane 6) 
were applied to Ni-NTA columns (500-µl bed volume) equilibrated with 50 mM Tris-Cl, 
pH 8.0, containing 1 mM MgCl2.  The column was washed with 1 ml of 50 mM Tris-Cl, 
pH 8.0, containing 200 mM NaCl and 0.01% DM, and then eluted with 1 ml of 50 mM 
Tris-Cl, pH 8.0, containing 200 mM NaCl, 200 mM histidine, and 0.5% octyl glucoside. 
The volume of column eluate was adjusted to that of the column effluent (unabsorbed 
plus wash).  2-µl aliquots were withdrawn from column elute (A) and column effluent (B) 
fractions and subjected to SDS-PAGE.  Samples in the gel were transferred to a 22-µm 
nitrocellulose membrane and treated with antibodies against R. sphaeroides ISP and 
subunit IV.  ProteinA-horseradish peroxide conjugate was used as a second antibody. 






       
Fig. 20A).  These results are consistent with the presence of increasing amounts of ISP 
and subunit IV in the Ni-NTA column effluents of cytb∆(433–445), cytb∆(427–445), 
cytb∆(425–445), and cytb∆(421–445) (see Fig. 20B).  It should be noted that subunit IV 
of the bc1 complex produced by R. sphaeroides BC-17 cells carrying the 
pRKD418/fbcFBCQ plasmid includes chromosomal and plasmid copies, whereas 
cytochrome b, c1, and ISP have only the plasmid copy.  These results indicate that the 
binding affinities of ISP and subunit IV to the complex are affected by the first 12 
residues (residues 421–432) at the N-terminal end of the C-terminal extra fragment of 
cytochrome b; binding affinity decreases as the fragment size decreases. 
The finding that the binding of ISP and subunit IV to cytochrome c1 are affected 
by the C-terminal extra fragment of cytochrome b is rather surprising, because they are 
not in the same subunit as cytochrome b. Perhaps interactions between the C-terminal 
extra fragment of cytochrome b and the N-terminal portion of ISP or subunit IV, located 
on the cytoplasmic side of the chromatophore membrane, are required for maintaining the 
structures of ISP and subunit IV for binding to cytochrome c1.  Thus, the mutations on the 
C-terminal extra fragment of cytochrome b induce conformational changes on 
ISP and subunit IV that weaken their binding affinities for cytochrome c1.  Alternatively, 
the binding of ISP or subunit IV to cytochrome c1 is through cytochrome b and mutation 
of the extra fragment not only decreases the binding affinity of cytochrome b to 
cytochrome c1, but also to ISP and subunit IV. 
 
The Abnormality of Electrophoretic Mobilities of C-terminal 





       
 
 
Fig.21. Comparison of electrophoretic behavior of 
cytochrome b in purified complement and mutant 
cytochrome bc1 complexes under various conditions. 
Purified complement and mutant cytochrome bc1 
complexes (50 pmol of cytochrome c1) were subjected  to 
SDS-PAGE with a separation gel containing T=12.5% and 
C=3% (panel A); and T=16.5% and C=4% (panel B). Lane 
1, prestained molecular weight standards; lanes 2-6, 
cytochrome bc1 complexes from wild-type, cytb∆(433–
445), cytb∆(427–445), cytb∆(425–445), and cytb∆(421–
445), respectively.  T stands for the total concentration of 







       
Fig.21. shows electrophoretic mobility of wild-type and C-terminal-truncated 
cytochrome b in separation gels containing two concentrations of acrylamide (T) and 
bisacrylamide (C).  In a separating gel having T =12.5% and C = 3%, a system used 
routinely for SDS-PAGE analysis of the R. sphaeroides bc1 complex, wild-type and 
mutant bc1 complexes of cytochrome b of cytb∆(433–445), cytb∆(427–445), cytb∆(425–
445), and cytb∆(421–445) have Rf values of 16.2, 17.5, 18.5, 19, and 19 mm, respectively 
(see Fig. 21A).  As expected, the Rf values of cytochrome c1, ISP, and subunit IV in 
mutant bc1 complexes are the same as those in the wild-type complex, because shortening 
the C-terminal extra fragment of cytochrome b should not affect the molecular masses of 
other subunits in the complex.  The Rf values of cytochrome b obtained in these mutant 
complexes are larger than the calculated values, as the molecular mass of cytochrome 
b is decreased by 1200, 1947, 2206, 2588, respectively, from that of wild-type 
cytochrome b.  It should be noted that the larger than calculated Rf values observed are 
not because of reduction of the molecular mass of mutant b proteins by proteolytic 
enzyme digestion, because the molecular mass of cytochrome b in the cytb∆(421–445) 
mutant complex, determined by MALDI-TOF mass analysis, is 47,264, which 
corresponds to the calculated value. 
To further confirm that C-terminal-truncated cytochrome b have abnormal 
electrophoretic mobility in SDS-PAGE, purified wild-type and mutant cytochrome bc1 
complexes were subjected to SDS-PAGE using a separating gel having T =16% 
and C= 4% (see Fig. 21B).  The electrophoretic mobility of wild-type R. sphaeroides 
cytochrome b, relative to cytochrome c1, is decreased when the concentrations of T and C 





       
and c1 enables us to obtain the Rf values for the cytochrome b mutants, relative to 
cytochrome c1.  The values are: 0.70, 0.76, 0.81, 0.84, and 0.86, respectively.  These 
values are larger than those calculated.  Thus, cytochrome b with decreasing lengths of 
the C-terminal extra fragment exhibits abnormal electrophoretic mobility in SDS-PAGE. 
Perhaps removal of the C-terminal extra fragment in cytochrome b makes cytochrome b 
protein assume a molecular shape more globular than the wild-type protein, in the 
presence of SDS, which moves faster in SDS-PAGE than expected. 
 
 
Effect of Mutations on the Rieske Iron-Sulfur Cluster 
 
Western blotting and SDS-PAGE analysis indicate that the amount of ISP in the 
purified bc1 complex decreases as the C-terminal extra fragment of cytochrome b 
decreases; no ISP is detected in the complex with cytochrome b lacking this extra 
fragment.  To see whether or not the mutations on the C-terminal extra fragment of 
cytochrome b also affect the microenvironments of the iron sulfur cluster, EPR spectra of 
the [2Fe-2S] cluster in complement and mutant bc1 complexes were determined and 
compared (see Fig.22). 
When complement and mutant complexes of cytb∆(433–445), cytb∆(427–445), 
cytb∆(425–445), and cytb∆(421–445), at a cytochrome b concentration of 230 µM, were 
reduced by a small excess of ascorbate, the EPR signal of the Rieske iron sulfur cluster in 
the complement complex is essentially the same as that previously reported for the wild-





       
 
 
Fig.22. EPR spectra of the [2Fe-2S] cluster of the Rieske iron-sulfur protein in purified 
bc1 complexes from the complement and mutants cytb∆(433–445), cytb∆(427–445), 
cytb∆(425–445), and cytb∆(421–445).  Purified complement and mutant bc1 complexes 
(230 µM cytochrome b) were treated with a small excess of ascorbate solution to fully 
reduce cytochrome c1 and frozen in liquid nitrogen.  Panel A, spectra obtained from 
samples scanning once from 3200 to 4000 G magnetic field; panel B, enlarged spectra at 
the gx region.  The gy signal amplitude in mutant complexes have been adjusted to about 
the same as that in the complement complex by scanning the cytb∆(433–445), 
cytb∆(427–445), and cytb∆(425–445) complexes, through the magnetic field, once, twice, 
and five times, respectively.  EPR spectra were recorded at 7 K with the following 
instrument settings: microwave frequency, 9.3 GHz; microwave power, 2.2 milliwatts; 
modulation amplitudes, 6.3 G; modulation frequency, 100 kHz; time constant, 665.4 ms; 








       
(see Fig. 22A).  The signatures of gy and gz of [2Fe-2S] cluster in the cytb∆(433–445), 
cytb∆(427–445), and cytb∆(425–445) mutant complexes are the same as those detected  
in the complement complex, but with signal amplitudes decreasing as the C-terminal 
extra fragment of cytochrome b shortens (see Fig.22A).  No EPR spectrum of the [2Fe-2S] 
cluster is detected in the cytb∆(421–445) mutant complex.  These results are consistent 
with Western blot results showing that the amount of ISP in the bc1 complex decreases as 
the C-terminal extra fragment of cytochrome b decreases and no ISP is detected in the 
complex that has cytochrome b lacking the entire C-terminal extra fragment. 
In contrast to gy and gz, the gx signal of [2Fe-2S] in mutant complexes of 
cytb∆(433–445), cytb∆(427–445), and cytb∆(425–445) mutant complexes change 
progressively from a relatively sharp peak with g=1.80 to a broadened peak with  
g=1.76 (see Fig.22B).  Whereas the gx signal from the cytb∆(433–445) mutant complex 
is quite sharp with g=1.80 peak, that from the cytb∆(425–445) mutant complex is 
broader with g=1.76 peak.  These results indicate that the alteration of the 
microenvironments of the [2Fe-2S] cluster increases as the C-terminal extra fragment of 
cytochrome b decreases.  This finding is somewhat surprising, because in the model 
structure of R. sphaeroides cytochrome bc1 complex (5), constructed by using the 
coordinates of subunits from beef heart mitochondrial bc1 complex, the Rieske iron-sulfur 
cluster is located at the head domain of ISP on the periplasmic side of the chromatophore 
membrane (positive side), whereas the C-terminal extra fragment of cytochrome b is 
located at the cytoplasmic side of this chromatophore membrane.  Thus, the effect of 
shortening the C-terminal extra fragment of cytochrome b on the EPR signature of the 





       
The line shape of the gx signature of [2Fe-2S] clusters is thought to be sensitive to 
the redox state of ubiquinone present in the Qo center (8-13).  The gx of bc1 from wild-
type R. sphaeroides is at g=1.80 when oxidized ubiquinone is present but shifts to 1.76 
and becomes much broader when ubiquinol is present.  In a study of the effect of 
extraction of ubiquinone, from chromatophore membranes, on the iron-sulfur cluster, 
Ding et al. (13) found that the gx signal became very broad and was located at ~1.765 
upon deletion of ubiquinone from the R. capsulatus chromatophore membrane.  Although 
the broadened, gx=1.76 resonance observed in the cytb∆(427–445) and cytb∆(425–445) 
mutant complexes resembles the “reduced state” or the “depleted state” spectrum, it is not 
because of changes the redox state of Q or a decrease of Q in the mutant complex, 
because no EPR spectrum of [2Fe-2S cluster] is detected in these two mutant complexes 
without treatment with ascorbate and the amount of Q in these two mutant complexes is 
the same as that in the complement complex.  It should also be noted that upon complete 
reduction by addition of dithionite, the broadened, gx=1.76 signal observed in the mutant 
complexes remains unchanged, whereas the gx=1.80 signals becomes broadened and 
shifts to a gx=1.76 signal, similar to the changes observed in the complement complex 
(8,9). 
The broadened, gx=1.76 EPR signal observed in the cytb∆(427–445) and 
cytb∆(425–445) mutant complexes is similar to the gx signal observed for the substitution 
of Leu for Phe-144 (F144L) in the cytochrome b from R. capsulatus (12) and of serine 
for Thr-160 in cytochrome b from R. sphaeroides (14).  The F144L bc1 complex in R. 
capsulatus and the T160S mutant complex in R. sphaeroides chromatophores were 





       
gx value at 1.765.  It was suggested that these properties of the F144L and T160S 
complexes resulted from a reduced affinity for quinone and quinol at the Qo site of the 
mutated complex.  One possibility, which could account for the decreased turnover rate 
of the cytb∆(427–445) and cytb∆(425–445) mutant complexes and their reduced state or 
the high field shift of the gx EPR signal, is that shortening the C-terminal extra fragment 
to less than 6 residues induces conformational changes at the Qo site, which raise the 




Effect of the Mutations on Redox potentials and EPR Characteristics 
of Cytochrome b in the bc1 Complex 
 
Fig. 23 shows redox titration curves of cytochrome b in the complement and 
C-terminal truncated cytochrome b mutant complexes.  Two redox components (bL and bH) 
are resolved from each of the titration curves and their redox potentials were calculated 
(see Fig. 23 and Table 4).  The redox potentials of bL and bH in the complement complex 
are -87 and 41 mV, respectively, similar to previously reported values (9).  The redox 
potentials of bL and bH in the cytb∆(433–445) mutant complex are -73 and 49 mV, 
respectively, indicating that deleting 13 residues has little effect on redox potentials of 
cytochrome b. In contrast, the redox potential of bL in mutant complexes of cytb∆(427–
445), cytb∆(425–445), and cytb∆(421–445) decreases by 28, 58, and 73 mV, respectively, 
and that of bH decreases by 16, 82, and 111 mV, respectively, compared with counterparts 





       
essential for maintaining redox potentials of b cytochromes.  The effect is larger in bH 
than in bL.  It should be noted that the amplitudes of the reductive and oxidative titrations, 
shown in Figs. 23 and 25, match so well because no protein denaturation occurs during 
the titrations, as a freshly thawed sample from the same batch of a given bc1 complex was 
used for each trial of reductive and oxidative titrations. 
 Fig.24 shows EPR spectra of the b cytochromes from the complement and mutant 
complexes, taken after the samples were reduced with sodium ascorbate to eliminate the 
overlapping signal from cytochrome c1.  The complement complex has features at g=3.53 
and g=3.77 previously assigned to cytochrome bH and bL, respectively, in the wild-type 
bc1 complex (8). The g=4.3 signal is thought to be nonspecific bound iron (III).  Similar 
EPR spectra were reported for the mitochondrial bc1 complex (15-18).  The cytochrome 
bH and bL signals in the cytb∆(433–445) mutant complex are the same as those in the 
complement complex, indicating that deletion of 13 residues does not perturb the heme 
environments of the b cytochromes in the complex.  A small effect on cytochrome bL 
EPR signal is observed in the cytb∆(427–445) mutant complex.  The positions of 
cytochrome bH and bL features in the cytb∆(425–445) and cytb∆(421–445) mutant 
complexes are shifted to 3.57 and 3.72, respectively, and the cytochrome bH signals are 
broadened significantly.  These results indicate that the first 6 residues (residues 421–426) 
at the N-terminal end of this C-terminal extra fragment are essential for maintaining 






       
 
Fig.23. Potentiometric titration of cytochrome b in purified complement and mutant bc1 
complexes.  The filled circles are reductive titration data and open circles are oxidative 
titration data.  For each bc1 complex two trials of oxidative and two trials of reductive 
titrations were performed.  For each trail of reductive and oxidative titrations, a freshly 
thawed sample from the same batch of a given bc1 complex was used.  The data points in 
oxidative and reductive titration curves are average of these two trials.  The solid lines 
represent the calculated n=1 redox titrations with an equal contribution from bL and bH 













Table 4.  The redox potentials (mV) of  cytochromes bL, bH, and 
c1 in wild type and  mutant bc1 complexes. 
        
   Midpoint potentials (mV)a
  Preparations 
  cytbH    cytbL     cytc1
complement   41±8  -87±8  237±6 
cytb∆(433-445)   49±5  -73±5 227±10
cytb∆(427-445)   25±10 -115±10 165±4 
cytb∆(425-445)  -41±6 -145±6 170±7 
cytb∆(421-445)  -70±5 -160±5 187±5 
 
aData on standard deviations of the mid-point potentials 
                              were obtained from four trials of titrations. 
 


















Fig.24. EPR spectra of cytochromes bH and bL in purified complement and mutant 
cytochrome bc1 complexes.  Sample preparations and instrument settings were the same 
as those described in the legend to Fig.22, except that the microwave power used was 








       
 
Effect of the C-terminal Extra Fragment of 
Cytochrome b on Cytochrome c1
 
Fig. 25 shows redox titration curves of cytochrome c1 in complement and mutant 
complexes.  The redox potentials of cytochrome c1 in these bc1 complexes, calculated to 
be 237, 227, 165, 170, and 187 mV, respectively (see Fig. 25 and Table 4), indicate that 
the redox potential of cytochrome c1 is affected by deleting more than 13 residues from 
the C terminus of cytochrome b. In the proposed structural model of the R. sphaeroides 
cytochrome bc1 complex, the C-terminal extra fragment of cytochrome b is located on the 
cytoplasmic side of the chromatophore membrane where N-terminal portions of 
cytochrome c1, ISP, and cytochrome b also reside. Heme c1 is located on the periplasmic 
side of the chromatophore membrane.  Perhaps interactions between the first 12 residues 
from the N-terminal end of the C-terminal extra fragment of cytochrome b and residues 
of cytochrome b, cytochrome c1, or ISP on the cytoplasmic side stabilize the structure of 
cytochrome c1 and maintain its redox potential.  Thus, the effect on the redox potential of 
cytochrome c1 by the C-terminal extra fragment of cytochrome b is a long range effect. It 
has been previously reported that redox midpoint potentials of cytochrome c1 are affected 
by substitutions in cytochrome b (17).  Moreover, the redox potential of heme c1, heme bL 
and heme bH of the deletion mutants cytb∆-(427-445), cytb∆-(425-445), and cytb∆-(421-
445) are lower than those of the w.t.. It is well know that redox potentials are pH 
dependent (19).  For example, the redox potential of ISP is pH dependent with a slope of 





       
N-terminal end of the C-terminal extra fragment of cytochrome b would change the local 
pH of heme c1, heme bL and heme bH.  Heme is iron-protoporphyrin IX with two 
propionate side chains attached.  The higher redox potentials of the w.t. in comparison 
with those of the mutants indicate that the one or both propionate might be protonated, 
due to the decrease of the local pH, which in turn, increases the electron affinity of the 
hemes. 
It should be noted again that the C-terminal extra fragment of cytochrome b is 
located on the cytoplasmic side of the chromatophore membrane, yet its deletion affects 
redox components, such as heme bH, iron-sulfur cluster, and heme c1, located on the 
periplasmic (opposite) side of the chromatophore membrane.  Therefore, these effects 
cannot be explained by direct interaction between the extra fragment of cytochrome b and 
the redox components or their ligands or their vicinity peptides.  These long range effects 
are probably because of globular changes in the deleted mutant complex.  That deleted 
cytochrome b proteins have electrophoretic mobilities greater than those of comparable 
molecular mass, in SDS-PAGE, suggests that the deleted cytochrome b proteins are more 
globular than the unaltered protein. 
Very recently, our collaborator Di, X. got a new R. sphaeroides bc1 crystal 
structure at 2.9 Å (unpublished data).  In this structure the assembly of the three core 
subunits, cytochrome b, cytochrome c1 and the iron-sulfur-protein (Fig. 26) are very 
similar to those in mitochondrial bc1 (21).  The iron-sulfur protein in R. s. bc1 crosses 
over as in mitochondrial bc1, connecting one molecule of cytochrome b to the adjacent 
one.  Since R. s. bc1 is structurally unsupported by supernumerary subunits (with the 





       
to crystallize with them), it must depend entirely on insertions and extensions both at the 
amino- and carboxyl termini of cytochrome b in order to maintain a global structure.  
This 3D-structure reveals that the last 15 residues are flexible and unlikely to be involved 
in maintaining the stability of the complex, which agrees well with our result that the 
fragment (residues from 432 to 445) is not essential for the function or assembly of the 
complex.  The removal of i-helix (425-433) is expected to destabilize de-helix to which it 
is bound via several hydrogen bonds.  The i-helix, the de-helix and the C-terminus of 
cytc1 are located very close to each other, suggesting mutual structural dependence. 
Consequently, removal of the i-helix explains the observed reduction of cyt c1 binding 
and in turn the loss of the ISP, which also agree well with our result that the first 12 
residues (residues 421-432) affect ISP and cytb binding affinity for cytc1.  As a whole, 
the new structural data about the C-terminal extra-fragment of cytb are consistent with 
our biophysical and biochemical experimental conclusion that this extra-fragment is very 












       
 
Fig.25. Potentiometric titration of cytochrome c1 in purified complement and mutant bc1 
complexes.  The filled circles are reductive titration data and open circles are oxidative 
titration data.  The solid lines represent the calculated n=1 redox titrations with the 
















Fig.26. The new crystal structure of R. sphaeroides bc1 at 2.9Å (unpublished data). 
















       
References 
 
1. Trumpower, B. L., and Gennis, R. B. (1994) Annu Rev Biochem 63, 675-716 
2. Ljungdahl, P. O., Pennoyer, J. D., Robertson, D. E., and Trumpower, B. L. (1987) 
Biochim Biophys Acta 891(3), 227-241 
3. Yang, X. H., and Trumpower, B. L. (1988) J Biol Chem 263(24), 11962-11970 
4. Phillips, J. D., Graham, L. A., and Trumpower, B. L. (1993) J Biol Chem 268(16), 
11727-11736 
5. Yu, L., Tso, S. C., Shenoy, S. K., Quinn, B. N., and Xia, D. (1999) J Bioenerg 
Biomembr 31(3), 251-257 
6. Xiao, K., Liu, X., Yu, C. A., and Yu, L. (2004) Biochemistry 43(6), 1488-1495 
7. Mitchell, P. (1976) J Theor Biol 62(2), 327-367 
8. McCurley, J. P., Miki, T., Yu, L., and Yu, C. A. (1990) Biochim Biophys Acta 
1020(2), 176-186 
9. Andrews, K. M., Crofts, A. R., and Gennis, R. B. (1990) Biochemistry 29(11), 
2645-2651 
10. Matsuura, K., Bowyer, J. R., Ohnishi, T., and Dutton, P. L. (1983) J Biol Chem 
258(3), 1571-1579 
11. Meinhardt, S. W., Yang, X. H., Trumpower, B. L., and Ohnishi, T. (1987) J Biol 
Chem 262(18), 8702-8706 
12. Robertson, D. E., Daldal, F., and Dutton, P. L. (1990) Biochemistry 29(51), 
11249-11260 
13. Robertson, D. E., Ding, H., Chelminski, P. R., Slaughter, C., Hsu, J., Moomaw, C., 
Tokito, M., Daldal, F., and Dutton, P. L. (1993) Biochemistry 32(5), 1310-1317 
14. Mather, M. W., Yu, L., and Yu, C. A. (1995) J Biol Chem 270(48), 28668-28675 
15. de Vries, S., Albracht, S. P., and Leeuwerik, F. J. (1979) Biochim Biophys Acta 
546(2), 316-333 
16. Salerno, J. C., McCurley, J. P., Dong, J. H., Doyle, M. F., Yu, L., and Yu, C. A. 
(1986) Biochem Biophys Res Commun 136(2), 616-621 






       
18. Orme-Johnson, N. R., Hansen, R. E., and Beinert, H. (1971) Biochem Biophys Res 
Commun 45(4), 871-878 
19. Dutton, P. L. (1978) Methods Enzymol 54, 411-435 
20. Link, T. A. (1997) FEBS Lett 412(2), 257-264 
21. Xia, D., Yu, C. A., Kim, H., Xia, J. Z., Kachurin, A. M., Zhang, L., Yu, L., and 


































Differential Scanning Calorimetry Study of Extra Fragment of  
Iron-sulfur Protein (Residues 96-107) of Cytochrome bc1 




To confirm that the extra fragment of ISP of R. sphaeroides cytochrome bc1 
complex is required for protein stability, we studied the thermotropic properties of 
cytochrome bc1 complexes from wild type and the mutant of ISP(96-99)A in the extra 
fragment of ISP by differential scanning calorimetry (DSC).  When purified cytochrome 
bc1 complexes from wild type and mutant were subjected to DSC analysis, they went 
endothermic thermodenaturation with transition temperatures (Tm) at 46.3 and 40.7˚C, 
respectively. The change of enthalpy (∆H) (46.3 Kcal/mol) of wild type protein was much 
higher than that (27.5 Kcal/mol) of mutant bc1 complex.   These results further establish 
that the loss (or decrease) of bc1 activity in extra fragment mutants results from a lack (or 












The cytochrome bc1 complex (also known as ubiquinol-cytochrome c reductase or 
Complex III) is an essential segment of the energy-conserving, electron transfer chain of 
the mitochondria and many respiratory and photosynthetic bacteria (1).   This complex 
catalyzes electron transfer from ubiquinol to cytochrome c (c2 in bacteria) and 
concomitantly translocates protons across the membrane to generate a membrane 
potential (∆Ψ) and pH gradient (∆pH) subsequently used by the ATP synthase to produce 
ATP.   All the cytochrome bc1 complexes contain three core subunits, cytochrome b, 
cytochrome c1, and Rieske iron sulfur protein (ISP), which house two b-type hemes (bL 
and bH), one c-type heme (heme c1), and a high potential [2Fe-2S] cluster, respectively. In 
addition to these three core subunits, the cytochrome bc1 complex also contains varying 
numbers (one to eight) of non-redox containing subunits, known as supernumerary 
subunits (2,3). 
 Although the function of supernumerary subunits in the cytochrome bc1 complex is 
not yet fully understood, it has been suggested that the structure of a core subunit in the 
mitochondrial complex may be stabilized through interactions between a core subunit and 
its neighboring supernumerary subunits (4), thus keeping its redox groups in defined 
positions.  Since the bacterial complexes contain none (or one) supernumerary subunit, 
maintaining the structural stability of a core subunit(s) in the bacterial complex may 
result from interactions between a part of a core subunit and another part of the same 





       
core subunits in bacterial complexes are generally bigger than their counterparts in the 
mitochondrial complex. 
Sequence alignment of bacterial ISP, cytochrome b, and cytochrome c1 with their 
counterparts in the mitochondrial complexes reveals four extra fragments in bacterial 
cytochrome b and one each in bacterial ISP and cytochrome c1 (5).  These extra 
fragments are modeled into the structure of Rhodobacter sphaeroides bc1 complex by 
using coordinates from the corresponding supernumerary subunits in the mitochondrial 
enzyme (5).  These findings encouraged us to suggest that these extra fragments may 
possess mitochondrial supernumerary subunit function in stabilizing the structure of the 
core subunits in the bacterial complex.  This suggestion is further supported by the recent 
finding that the extra fragments of R. sphaeroides ISP (residues 96-107) and cytochrome 
b (residues 421-445) are found to be essential for maintaining structural integrity of the 
bc1 complex (6,7) (see Fig. 16).  Additionally, Xiao et al (8) reported that the presence of 
more supernumerary subunits in the mitochondrial cytochrome bc1 complex apparently 
contributes to the thermal stability of the complex based on comparison of the 
thermotropic properties of mitochondrial bc1 and bacterial bc1 through the differential 
scanning calorimetry (DSC) study.  
DSC is a thermal analysis technique which has been used to measure the energy 
absorbed or emitted by a sample during its thermodenaturation.  When thermal transition 
occurs in the sample, DSC provides a direct calorimetric measurement of the transition 
energy at the temperature of the transition.  Such measurements provide qualitative and 
quantitative information about physical and chemical changes that involve endothermic 





       
applications, such as studying stability and domain structure of proteins and nucleic acids; 
detecting impurity or minor components in phospholipid sample; studying protein:protein, 
protein:ligand or protein:lipid interaction in membrane or in the detergent dispersed form.  
The thermodenaturation temperature (Tm) and the change of enthalpy (∆H) are the two 
parameters used to assess the thermotropic properties of the samples. 
To further establish that the extra fragment of ISP of R. sphaeroides cytochrome 
bc1 complex is required for protein stability, we studied the thermotropic properties of 
cytochrome bc1 complexes from wild type and mutants in the extra fragment of ISP. 
Decrease in Tm and ∆H in mutant is expected.  Herein, we report the procedure and 
results of DSC study of mutant of ISP(96-99)A in the extra fragment of ISP. 
 
 
Results and Discussion 
 
 
Choice of the mutant of ISP(96-99)A  among the extra fragment ISP mutants 
 
 
To study the role of the extra fragment of ISP in the R. sphaeroides bc1 complex, 
several mutants expressing His-tagged cytochrome bc1 complexes with deletion or single- 
or multiple-alanine substitution at various positions of this fragment (residues 96-107) 
were generated.  They are: full deletion mutant ISP∆(96-107), alanine substitution 
mutants ISP(96-107)A, ISP(96-99)A, ISP(100-103)A, ISP(104-107)A, ISP(D104A), 





       
ISP(N97A), ISP(R99A) (6). 
Because the bc1 complex is absolutely required for the photosynthetic growth of R. 
sphaeroides, whether this ISP extra fragment is crucial to the complex can be determined 
by assaying photosynthetic growth.  Both full deletion mutant [ISP∆(96-107)]  and full 
alanine substation [ISP(96-107)A] cell can not grow photosynthetically, indicating that 
inability to grow photosynthetically of full deletion mutant cell is due to the essentiality 
of the extra fragment for the bc1 complex, not due to improper assembly or folding 
because of the large deletion, and this region maybe required for bc1 complex activity. 
The amino acid residues, rather than the length of the extra fragment, are critical, because 
the alanine substituted fragment should have the same length as the wild type fragment.  
To locate the critical regions of the extra fragment, three alanine substitution 
mutants, ISP(96-99)A, ISP(100-103)A, ISP(104-107)A, were generated.  The first four 
residues (residues 96-99) are not critical as the ISP(96-99)A mutant grows 
photosynthetically at a rate comparable to that of wild type cells.  Residues 100-103 may 
possess the supernumerary subunit’s function, since the ISP(100-103)A mutant has a 
growth behavior similar to that of the subunit IV lacking R. sphaeroides (RS∆IV) cells 
(9), the last four residues (residues 104-107) are critical because the ISP(104-107)A 
mutant does not grow photosynthetically.   The essentiality of the ISP extra fragment to 
the bc1 complex is in the order residues 104-107>residues100-103> residues 96-99, since 
the ISP(96-99)A, ISP(100-103)A, and ISP(104-107)A mutant membranes have 48%, 9%, 
and 0% of the ubiquinol-cytochrome c reductase activity found in the complement 
chromatophores.  The role played by the extra fragment of ISP is not individual amino 





       
substitution mutant chromatophores, T96A, N97A, R99A, N100A, N10A, I103A, 
D104A,G106A and G106L , have ubiquinol-cytochrome c reductase activity similar to 
that found in complement chromatophores. 
Absorption spectral analysis revealed that mutant membranes of ISP∆(96-107),  
ISP(96-107)A, ISP(104-107)A, ISP(100-103)A, and ISP(96-99)A have cytochrome b and 
c1+c2 contents and spectral characteristics similar to those of complement 
chromatophores, indicating that the mutation in the extra fragment of ISP does not affect 
the assembly of cytochrome b and c1/c2 into the membrane.   Western blotting analysis 
using antibodies against subunit IV shows that the mutations do not affect assembly of 
subunit IV into the membrane, as all of the mutant membranes contain the same amount 
of subunit IV as the complement membrane.   When the cytochrome bc1 complexes were 
purified from mutant membranes by dodecyl maltoside solubilization and Ni-NTA 
column chromatography, all but the ISP(96-99)A complex contained two subunits 
corresponding to cytochrome b and c1.   Purified ISP(96-99)A complex contains four 
protein subunits with ISP and subunit IV in decreased amounts compared to the purified 
wild-type complex.   The ratio of b/c1 in all purified mutant complexes is similar to that 
in the wild-type complex, which indicates that mutation does not affect the binding 
affinity of cytochrome b to cytochrome c1, but greatly decreased the binding affinity of 
subunit IV to cytochrome c1 or to cytochrome b.  The simultaneous loss of ISP and 
subunit IV when the ISP extra fragment is altered may result from induced changes on 
subunit IV which decrease its affinity for cytochrome b or c1 in the purified complex. The 
two-subunit bc1 complexes purified from ISP∆(96-107),  ISP(96-107)A, ISP(100-103)A, 





       
complex is almost restored after the incubation of these two subunit bc1 complexes with 
subunit IV and purified ISP. 
However, Western blot analysis with antibody against R. sphaeroides ISP revealed 
that mutant membranes of ISP∆(96-107),  ISP(96-107)A, ISP(104-107)A contain no 
detectable ISP and that the ISP(100-103)A, and ISP(96-99)A mutant membranes have 5% 
and 50%, respectively, of the amount of ISP found in the complement membrane, which 
indicate that the loss (or decrease) of cytochrome bc1 complex activity in the ISP extra 
fragment mutant membranes is due to a lack (or decrease) of ISP.  Although ISP(100-
103)A, and ISP(96-99)A mutation cause a decrease in the amount of ISP in the membrane, 
they do not affect the microenvironment of the iron-sulfur cluster because the [2Fe-2S] 
clusters in these two mutant membranes had EPR spectral features identical to those 
observed in complement chromatophores.  No [2Fe-2S] cluster is detected in mutant 
membranes of ISP∆(96-107),  ISP(96-107)A, ISP(104-107)A, since they contain no ISP.  
The observation of a lack of (or decrease in) ISP in mutant membranes of 
ISP∆(96-107),  ISP(96-107)A, ISP(104-107)A, ISP(100-103)A, and ISP(96-99)A is due 
to instability of the mutant protein, not due to the instability of the mutant mRNA because 
all mutant cells were found to have the same amounts of ISP mRNA as complement cells. 
The amounts of ISP in the cell lysate, 200,000g supernatant and precipitate (membrane) 
fractions, from mutant cells during membrane preparation were measure and compared 
with those obtained from complement cells in order to further confirm that a lack (or 
decrease) of ISP in mutant membranes results from mutant ISP protein instability. Freshly 
prepared mutant cell lysates of ISP∆(96-107),  ISP(96-107)A, ISP(96-99)A, ISP(100-





       
content of complement cell lysates as determined by Western blot.  No ISP was found in 
any of the supernatant fractions after centrifugation of these cell lysates.  Less than 60% 
and 10% of the ISPs in the ISP(96-99)A and ISP(100-103)A mutant cell lysates are 
recovered in the membrane fraction, respectively.  No cell lysate ISP from the ISP∆(96-
107),  ISP(96-107)A, ISP(104-107)A mutants is recovered in their respective membrane 
fractions.  The low (or lack of) recovery of ISP in the membrane fractions of these 
mutants results from degradation of mutant ISP during centrifugation.  Time course 
analysis revealed a progressive decrease in ISP in these mutant cell lysates, but not in the 
complement cell lysate.  
All of these observations suggested to us that a decrease in ISP in the mutant 
membrane is due to the instability of assembled mutant ISP.  The confirmation of this 
idea may be obtained from the comparison of thermotrophic properties of purified 
cytochrome bc1 complexes from wild type and mutants.  Among the mutants of the extra 
fragment of ISP, only mutant ISP(96-99)A has decreased bc1 activity although it still has 
four subunits, ISP, cytb, cytc1, and subunit IV, which is the same as wild type.  To 
unambigously establish the idea mentioned, the protein from mutant ISP(96-99)A might 
be the best candidate to be chosen for the further study.  
 
 
Differential Scanning Calorimetry (DSC) study of ISP(96-99)A 
 
DSC has been widely used to study protein stability.  The thermodenaturation 
temperature (Tm) and the change of enthalpy (∆H) are the two parameters used to assess 





       
and type of detergents used greatly affect the protein stability, for systematic comparison 
of protein stability, all bc1 preparations used in these DSC studies were in 0.5% 
octylglucoside.  When purified wild type cytochrome bc1 complex underwent 
thermodenaturation, it showed endothermic thermodenaturation with a Tm at 46.3°C and 
∆H of 46.3 kcal/mol.  Under identical conditions the mutant ISP(96-99)A has a Tm of 
40.7 °C and ∆H of 27.5 kcal/mol (see Fig. 27.).  The decrease in Tm and ∆H of the 
mutant complex indicates that it is less stable than the wild-type complex.  
From all the results mentioned above, the loss (or decrease) of bc1 activity in 
these mutant membranes results from a lack (or decrease) of ISP in the membrane due to 
ISP protein instability and not from mutations affecting the assembly of cytochromes b 
and c1 into the membrane, the binding affinity of cytochrome b to cytochrome c1, or the 












                                                Temperature (°C) 
 
Fig.27. DSC thermograms of ISP(96-99)A and wild-type bc1 complexes.  The red line is 
the thermogram of wild-type cytochrome bc1 complex.  The blue line is the thermogram  
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5-Br-Q0C10 Binding Site in Rhodobacter 
 sphaeroides bc1 complex 





The preliminary structural analysis of the low resolution of co-crystal of bovine 
bc1 complex with 5-Br-Q0C10 suggests that the binding site of 5-Br-Q0C10 is different 
from Qi site and Qo site.  Additionally, the crystal structure indicates that there is a 
channel connected to the cavity for the binding of 5-Br-Q0C10.  To elucidate this novel Q 
binding site, two sets of R. sphaeroides cytochrome b mutants expressing His6-tagged bc1 
complexes were generated and characterized.  One set of mutants, Y399F/W400F, 
Y399A/W400A, M343F/L370F, are constructed to interact with 5-Br-Q0C10.  Another set 
of mutants, I106C/V375C, Y109C/F374C, L110C/A371C, X(106,109,374,375)C, are 
designed to block the entrance of the putative channel.  All these mutants grew 
photosynthetically at a rate comparable to that of wild-type cells.  The bc1 complexes 
prepared from these mutants have the similar activity as that of the wild type complex. 
The Kms for Q0C10BrH2 determined with mutant chromatophores of cytb-(M343F), cytb-





       
cytb-(Y399A/W400A), and cytb-(M343F), are comparable with that of the wild type 
chromatophore or complex, respectively.  Also, the 5-Br-Q0C10 titration curves of all 
mutants showed the same pattern as that of the wild type, which is that low concentration 






 The mitochondrial respiratory chain, which provides more than 90% of the energy 
needed for aerobic cells by oxidative phosphorylation process, a universal process that 
converts most of the energy provided by foodstuffs into the general energy source ATP, 
contains four electron transfer complexes and an ATP synthase complex (1-3).  The 
cytochrome bc1 complex plays a crucial role in oxidative phosphorylation.  Within this 
process, the cytochrome bc1 complex connects hydrophobic ubiquinol and water-soluble 
cytochrome c, transferring electrons between these two freely diffusible intermediates 
and thereby linking the exergonic reaction to generating a proton gradient and membrane 
potential for ATP synthesis by ATP synthase (4,5).  
 Although the study of cytochrome bc1 has been intensive since its discovery in the 
early 1960s, our understanding of the bc1 complex has been greatly enhanced by the 
availability of crystallographic structures (6-10).  Unfortunately, none of the reported 
structures for cytochrome bc1 complex shows direct ubiquinone or ubiquinol binding. 





       
and Qi site inhibitors (11).  Because most of the Qo site inhibitors are reported to be 
noncompetitive inhibitors (12,13), their binding sites cannot be assumed to be the 
ubiquinol binding site.  Although the essential role of ubiquinone in mitochondrial 
electron transfer is well established (14-16), the interaction between Q and protein are not 
yet fully understood. Establishing the nature of ubiquinol binding site is very important in 
the mechanistic study of this complex.  
 To study the ubiquinol binding site, the most direct approach is to co-crystallize 
the bc1 complex with ubiquinol or ubiquinol-like compound. However, typical difficulty 
in co-crystallize with ubiquinol is that ubiquinol can not be seen in the crystal.  To 
overcome this, one of the feasible methods is synthesizing Q-derivatives to enhance the 
diffraction signal.  Recently, we synthesized 5-Br-Q0C10, whose structure is showed in 
Fig. 28. Due to the special property of the bromine in this Q derivative, we can locate 
bromine first, and then this Q-like compound can be located.  More recently, we co-
crystallized bovine mitochondrial bc1 with 5-Br-Q0C10 at low resolution.  Surprisingly, 
the preliminary structural data shows that the binding site of 5-Br-Q0C10 is different from 
putative Qo and Qi site, it also show there is a channel connected to the cavity for the 
binding of 5-Br-Q0C10 (see Fig.29.).  There was electron density among amino acid 
residues L357 and Y358 of helix H (Y399 and W400 in R. sphaeroides), residue L328 of 
helix G (L370 in R. sphaeroides), and residue L301 of helix F (M343 in R. sphaeroides) 
surrounding the putative cavity for the 5-Br-Q0C10 binding.  Residues I92, Y95, M96, 
V329, L332, L333 (I106, Y109, L110, A371, F374, and V375, respectively, in R. 
sphaeroides) are probably involved in the putative channel connected to the cavity of the 





























Fig.29. The relative binding location of 5-Br-Q0C10 to one of Qo site inhibitor 
(stigmatellin), Qi site inhibitor (antimycin) and redox centers in the cytochrome bc1 
complex.  Stigmatellin in green, antimycin in red, and heme bL and bH in yellow.  The 
residues (Y399, W400) of helix H, residue (L370) of helix G, and residue (M343) of helix 







       
An effective way to test this hypothesis is to systematically mutate the residues 
involved in the binding of 5-Br-Q0C10 and to follow the biochemical biophysical 
characterization of the resulted mutant proteins.  Herein, we report procedures for 
generating R. sphaeroides mutants with mutations involved in this putative Q binding site 
in the bc1 complex.  The photosynthetic growth behavior, cytochrome bc1 complex 
activity, and Km titrations in bc1 complexes from wild type and mutant strains were 






Materials—Cytochrome c (horse heart, type III) was from Sigma.  N-Dodecyl-β-D-
maltoside and N-dodecyl-β-D-glucoside were from Anatrace.  Ni-NTA gel and Qiaprep 
Spin Miniprep kit were from Qiagen.  2,3-Dimethoxy-5-methyl-6-(10-brimodecyl)-1,4-
benzoquinol (Q0C10BrH2) was prepared in our laboratory as previously reported (17). All 
other chemicals were of the highest purity commercially available. 
 
 
Growth of Bacteria—Escherichia coli cells were grown at 37°C in LB medium. 
Photosynthetic growth conditions for Rhodobacter sphaeroides were essentially as 
described previously (18).  The concentration and antibiotics used were: ampicillin, 125 





       
sphaeroides; and trimethophrim, 100 µg/ml for E. coli, 30 µg/ml for R. sphaeroides. 
 
 
Generation of R. sphaeroides Strains Expressing the His6-tagged bc1 Complexes With 
Mutations at the Binding Site of 5-Br-Q0C10 and the Entrance of That Site—Mutations 
were constructed by using the QuikChangeTM XL site-directed mutagenesis kit from 
Stratagene. A double-stranded plasmid pGEM7Zf(+)-fbcFB was used as a template and 
forward and reverse primers were used for PCR amplification. The pGEM7Zf(+)-fbcFB 
plasmid was constructed by ligating the EcoRI-XbaI fragment from pRKDfbcFBC6HQ 
(19) into EcoRI and XbaI sites of the pGEM7Zf(+) plasmid.  The primers used are given 
in Table 5. 
 There are two kinds of fragments: one is a 962-base pair BsteII-XbaI fragment, 
the other is a 3379-base pair EcoRI-XbaI fragment depend on the location of mutation 
site(s) on cytochrome b after mutagenesis.  These two fragments were ligated into BsteII-
XbaI or EcoRI-XbaI sites of pRKD418fbcFBKmBPC6HQ plasmid (19).  Loss of kanamycin 
resistance was then used to screen for recombinant plasmids containing the mutant 
cytochrome b gene. 
 The pRKD418fbcFBmC6HQ plasmid in E.coli S17-1 cells was mobilized into R. 
sphaeroides BC-17 cells by a plate-mating procedure (19).  The presence of engineered 
mutations was confirmed by DNA sequencing of the 962-base pair BsteII-XbaI or 3379-
base pair EcoRI-XbaI fragment after photosynthetic growth as previously reported (19). 
DNA sequencing was performed by the Recombinant DNA/Protein Core Facility at 












Table 5. Oligonucleotide used for site-directed mutagenesis for study the 









































       
Enzyme Preparation and Activity Assay—Chromatophores were prepared from frozen cell 
paste, and cytochrome bc1 complexes with a His6 tag placed at the C terminus of 
cytochrome c1 were purified from chromatophores as preciously reported (20).  To assay 
the cytochrome bc1 complex activity, chromatophores or purified cytochrome bc1 
complexes were diluted with 50 mM Tris-Cl, pH 8.0, containing 200 mM NaCl and 
0.01% N-dodecyl-β-D-maltoside (DM) to a final concentration for cytochrome b of 3 µM. 
Appropriate amounts of the diluted samples were added to 1 ml of assay mixture 
containing 100mM Na+/K+ phosphate buffer, pH 7.4, 1 mM EDTA,  100 µM cytochrome 
c, and 25 µM  Q0C10BrH2.  30 µM potassium cyanide was added to the assay mixture 
when bc1 activity in chromatophores was determined.  For determination of apparent Km 
for Q0C10BrH2, various concentrations of Q0C10BrH2 were used.  Activity was determined 
by measuring the reduction of cytochrome c (the increase of absorbance at 550 nm) in a 
Shimadzu UV 2101 PC spectrophotometer at 23°C, using a millimolar extinction 
coefficient of 18.5 for calculation.  The nonenzymatic oxidation of Q0C10BrH2, 
determined under the same conditions, in the absence of enzyme, was subtracted. 
Although the chemical properties of Q0C10BrH2  are comparable with those of Q0C10H2, it 
is a better substrate for the cytochrome bc1  complex (17).  The unit of specific activity is 
µmol of cytochrome c reduced/min/nmol of cytochrome b. 
 
Titration of the Cytochrome bc1 Complex Activity in Complement and Mutants 
Chromatophores or Proteins with Various Concentrations of Q0C10BrH2 or 5-Br Q0C10. 
Chromatophores or purified cytochrome bc1 complexes were diluted with 50 mM Tris-Cl, 





       
concentration for cytochrome b of 3µM, 3 µl of the diluted sample were added to 1 ml of 
assay mixture containing 100 mM Na+/K+ phosphate buffer, pH 7.4, 1 mM EDTA, 50 µM 
cytochrome c, and indicated concentrations of Q0C10BrH2 or 5-Br-Q0C10. 
 
Other Biochemical and Biophysical Techniques—The contents of cytochrome b (21) and 




Results and Discussion 
 
Choice of Residues and Strategy for the Study--The low resolution co-crystal structure of 
bovine mitochondrial bc1 complex with 5-Br-Q0C10 showed that amino acid residues 
L357, Y358 of helix H, residue L328 of helix G, and residue L301 of helix F are 
surrounding the putative cavity for the 5-Br-Q0C10 binding, and residues I92, Y95, M96, 
V329, L332, L333 are probably involved in the putative channel connected to the cavity 
of the binding of 5-Br-Q0C10.  According to the sequence alignment, we picked up the 
correspondent residues of R. sphaeroides bc1 complex to study the 5-Br-Q0C10 binding 
site, including (Y399, W400) of helix H, residue (L370) of helix G, and residue (M343) 
of helix F, and the mutations blocking the entrance of the channel, including I106, Y109, 
L110, A371, F374, and V375.  
There are mainly two ways of quinone interacting with amino acid residues, one 





       
residue, the other is the interaction between the aromatic ring of quinone and  aromatic 
ring of amino acid residues, such as W and Y.  Therefore, we generated two double 
mutants, one is X(399,400)F to get rid of hydrogen bonding, the other is X(399,400)A to 
get rid of aromatic-aromatic interaction.  On the other hand, the crystal structure shows 
that the cavity of the 5-Br-Q0C10 binding is very compact, so we mutated the relative 
small residues, such as L370 and M343, in this cavity to the bulky residues, such as F, in 
order to squeeze out 5-Br-Q0C10, we generated three mutations, L370F, M343F, and 
X(343,370)F.  
In order to blocking the entrance of the channel, we generated the mutants with 
double or tetra cysteine substitution, such as I106C/V375C, Y109C/F374C, 
L110C/A371C, X(106,109,374,375)C.  
 
Titration of the Cytochrome bc1 Complex Activity in Complement and Mutants 
Chromatophores or Proteins with Various Concentrations of Q0C10BrH2—Since we hope 
we can extrapolate the quinol binding site by using Q-derivative compound, if the 
hypothesis is correct, the Km for the mutants should be different from that of the w..t.. 
Therefore, we titrated the cytochrome bc1 complex activity with various concentrations of 
Q0C10BrH2.  We did following titration: X(399,400)F (Fig.30.), M343F (Fig.31.), L370F 
(Fig.33), X(343,370)F (Fig.34).   To rule out the affect of detergent on Km, we also did 
titration of M343F chromatophore (Fig.32.).   Because the Km of M343F chromatophore 
is similar to that of purified protein of M343F, the detergent affect can be omitted.  As 
Table 6 shows, the Kms of the mutants is similar to that of the wild type. 





       
Chromatophores or Proteins with Various Concentrations of 5-BrQ0C10—We also did 5-
BrQ0C10.  We titrated X(343,370)F (Fig.35), X(399,400)A (Fig.36).  For X(399,400)A, 
although the pattern of titration curve is similar to that of w.t. (Fig.36), the value of every 
points is higher than that of w.t., so we incubated the X(399,400)A with endogenous 
Q0C10, then titrated with 5-BrQ0C10 to see any difference (Fig.36).  The possible 
explanation of the high value of every points is that X(399,400)A makes bc1 more 
accessible to 5-BrQ0C10.  We also did regular Km titration by using the samples at the 
same day, the Km and Vmax of X(399,400)A are similar to those of w.t..  We also did 
X(399,400)F titration, the sample was incubated with or without endogenous Q0C10 
(Fig.37). 
We also titrated the mutants with double or tetra cysteine substitution, such as 
I106C/V375C (Fig.38), Y109C/F374C (Fig.39), L110C/A371C (Fig.40), 
X(106,109,374,375)C (Fig.41) with 5-BrQ0C10.  
All of the 5-BrQ0C10 titration curve of mutants show the same pattern as that of 
w.t., which is that low concentration of 5-BrQ0C10 can active bc1 complex, high 
concentration of 5-BrQ0C10 inhibits the bc1 complex.  One explanation for this 


















Table 7. Km of the different mutants. 
 
 X(399,400)F(P)a M343F(C)b L370F(C) X(343,370)F(C) 
Km (µM) 1.69 1.27 1.67 1.41 
 










































































































































Fig.36. 5-Br-Q0C10 titration of X(399,400)A compared with w.t. (the purified  
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Saturation Transfer Electron Paramagnetic Resonance and 
Differential Scanning Calorimetry Studies of the Interaction 
between Cytochrome caa3 and F1F0-ATP Synthase from 




The interaction between cytochrome caa3 and F1F0-ATP synthase from the 
alkaliphilic Bacillus pseudofirmus OF4 was studied by differential scanning calorimetry 
(DSC) and by saturation transfer electron paramagnetic resonance (STEPR).  When these 
two purified complexes are embedded in phospholipids vesicles individually [(cca3) × PL, 
(F1F0) × PL)] or in combination [(cca3+F1F0) × PL] and subjected to DSC analysis, they 
undergo exothermic thermodenaturation with transition temperatures at 69, 57, and 46/75 
˚C, respectively.  The ∆H (-8.8 Kcal/mmol) of protein-phospholipid vesicles containing 
both cytochrome caa3 and F1F0 is smaller than that (-12.4 Kcal/mmol) of a mixture of 
protein-phospholipid vesicles formed from each individual electron transfer complex 
[(cca3 × PL) + (F1F0 × PL)].  These results suggest that a specific interaction between 





       
between these two complexes is provided by STEPR studies in which the rotational 
correlation time of spin-labeled caa3 (65 µs) increases significantly when the complex is 
mixed with F1F0 prior to being embedded in phospholipids vesicles (270 µs).  From these 
results, it is concluded that at least a part of cca3 and a part of F1F0 form a 




The facultative alkaliphile, Bacillus pseudofirmus OF4, grows well over a pH range 
extending from 7.5 to above 10.5 (1).  The organism possesses a branched respiratory 
chain with at least two terminal oxidases, cytochrome bd and cytochrome caa3 (2). 
Increased amounts of cytochrome caa3 are associated with two distinct growth conditions 
where the bulk electrochemical proton gradient (∆p) is low: pH 10.5 (3) or pH 7.5 in the 
presence of protonophore carbonyl cyanide m-chlorophenylhydrazone (CCCP) (4). 
Additionally, a CCCP-resistant mutant strain was found to contain constitutively elevated 
levels of cytochrome caa3 when grown at pH 7.5 (4). 
 Like mitochondria of eukaryotic organisms and most bacteria, alkaliphilic 
Bacillus pseudofirmus OF4 synthesizes ATP using a proton-coupled F1F0-ATP synthase 
via oxidative phosphorylation (5).  The widely confirmed chemiosmotic mechanism for 
ATP synthesis and other membrane-associated bioenergetic work requires establishment 
of ∆p during respiration and photosynthesis.  Coupling is achieved by the proton-
translocating nature of the reversible F1F0-ATP synthase (6).  Two properties of proton-





       
9.5, ATP synthesis utilizes a mechanism that depends upon the bulk transmembrane 
electrical potential, the ∆Ψ, but also depends upon a sequestered transfer of protons from 
the respiratory chain to the ATP synthase.  Firstly, the protonmotive driving force is very 
low at pH 10.5 and above, because the needs of pH homeostasis produce a large ∆pH, 
acid in.  Nonetheless, the ATP synthesized, as reflected in the observed phosphorylation 
potential, is even greater than at pH 7.5, where the ∆p is three times higher.  Secondly, 
artificially imposed diffusion potentials fail to energize ATP synthesis at pH values above 
9.5 (7).  
 We have hypothesized that robust alkaliphile oxidative phosphorylation at very 
alkaline pH values involves the required respiratory chain proton pumping to the bulk 
phase to establish a ∆p and also involves use of one or more specific respiratory chain 
complexes to transfer protons to F0 sector of the F1F0 ATP-synthase during dynamic 
protein-protein interactions (7).  In this way, the proton-translocating F1F0-ATPase 
accesses protons that have not completely equilibrated with the alkaline medium, 
accounting for greater synthesis than anticipated from the measured bulk ∆p and for the 
inefficacy of an imposed bulk potential.  The caa3 terminal oxidase is the best candidate 
for that interacting partner both because of its alkali-dependent expression and because of 
the observation that small mutational decreases in the level of this oxidase lead to a non-
alkaliphilic phenotype on non-fermentative substrates (3,8).  An alternative hypothesis 
that would not involve protein-protein interactions between a respiratory chain complex 
and the ATP synthase is that alkaliphile oxidative phosphorylation at high pH utilizes 
protons that are sequestered near the membrane surface in some trapped, delocalized 





       
account from the requirement of specific features of the alkaliphile F1F0-ATPase for ATP 
synthesis at high pH (10).  
 Using methods of differential scanning calorimetry (DSC) and saturation transfer 
electron paramagnetic resonance (STEPR), we had earlier been able to detect protein-
protein interactions between the bovine heart mitochondrial cytochrome c oxidase and 
F1F0-ATP synthase in the native membrane state (11).  Recently, we used these methods 
to study the interaction between cytochrome caa3 and ATP synthase from alkaliphilic 
Bacillus pseudofirmus OF4 in an attempt to test the hypothesis that protein-protein 
interactions are involved in ATP synthesis.  If the assays supported such interactions, they 
could then be used to assess the role of specific features of the ATP synthase and oxidase. 
The DSC study is based on the assumption that if two lipoprotein complexes exist 
separately in a phospholipid vesicle, no difference in thermotropic properties will be 
observed between protein-phospholipid vesicles formed from a mixture of two complexes 
and a mixture of protein-phospholipid vesicles formed individually from each complex. 
Differences in the thermodenaturation temperatures and enthalpy changes would suggest 
formation of a physical complex between cytochrome caa3 and ATP synthase.  In the 
STEPR study, the formation of a physical complex between cytochrome caa3 and ATP 
synthase will be indicated by an increase of rotational correlation time of spin-labeled 
cytochrome caa3.  Herein, we report experimental details and results of DSC and STEPR 
studies with cytochrome caa3 and ATP synthase embedded in phospholipid vesicles.  The 
results of DSC and STEPR indicate that cytochrome caa3 does indeed interact directly 







       
Material and methods 
Materials. 4-Maleimide-2,2,6,6-tetramethyl-1-piperidinyl-N-oxyl (MSL), 
Cytochrome c (horse heart, type III) and sodium cholate were from Sigma. N-Dodecyl-β-
D-maltoside (DM) and N-octyl-β-D-glucoside were from Anatrace.  Asolection was 
obtained from Associated Concentrates, Inc., and purified according to the procedure 
reported by Kagama et. al (12).  Centriprep-30 and Centricon-30 were bought from 
Amicon. Other chemicals were of the highest purity commercially available.  
Enzyme Preparations and Assays. Highly purified cytochrome caa3 and F1F0-ATP 
synthase from alkaliphilic Bacillus pseudofirmus OF4 were prepared and assayed 
essentially as reported previously (3,5).   
Preparation of Maleimide Spin-Labeled (MSL) Cytochrome caa3. Alkaliphile, 
Bacillus pseudofirmus OF4 cytochrome caa3, 20 mg/ml in 20 mM Tris-Cl, pH 8.0, 
containing 0.35 M NaCl, 1 mM EDTA, 0.1 mM PMSF, 0.05 % dodecyl maltoside, and 10 
% glycerol was incubated with a 5 molar excess of 4-maleimide-2,2,6,6-tetramethyl-1-
piperidinyl-N-oxyl (MSL) for 1 hour at room temperature.  The stock solution of MSL 
(10 mM) was made in 10 mM Tris-Cl /sucrose buffer, pH 8.0, containing 20% methanol. 
After incubation, the unreacted MSL was removed by passage through a D-SaltTM 
Excellulose Desalting Column from Pierce, equilibrated with 10 mM Tris-Cl buffer, 
containg 0.05 % dodecyl maltoside.  Fractions containing MSL-cytochrome caa3 were 
pooled and concentrated by Centriprep-30 and Centricon-30 to a protein concentration of 
approximately 20 mg/ml.  MSL-cytochrome caa3 obtained by this method contains no 
free spin-label.  The absence of free spin-label in the preparation was confirmed by the 





       
Preparation of Cytochrome caa3 and F1F0 Complex-Phospholipid Vesicles. The 
protein-phospholipid vesicles were prepared by the cholate-dialysis method reported by 
Racker (13).  Cytochrome caa3 complex, with or without MSL labeling, alone or in 
combination with F1F0, at a protein concentration of approximately 30 mg/ml, was mixed 
with an asolectin micellar solution (20 mg/ml in 50 mM phosphate buffer, pH 7.4) and a 
sodium cholate solution [20% (w/v) in water].  The final solution contained 7 mg/ml 
protein, 10 mg/ml sodium cholate, and 10.5 mg/ml asolectin.  After incubation at 4oC for 
30 min, the solution was dialyzed overnight against 500 volumes of 50 mM phosphate 
buffer, pH 7.4, with four changes of buffer to form vesicles.  The protein-phospholipid 
vesicles formed were collected as precipitated by centrifugation at 80,000 g for 1 h and 
were respended in 50 mM phosphate buffer, pH 7.4, to a protein concentration of suitable 
number.  The suspensions were used for the DSC and STEPR experiments. 
Differential Scanning Calorimetry.  All calorimetric measurements were performed 
with a CSC 6100 NanoII DSC from Calorimetry Science Corp.  The reference and 
sample solutions were carefully degassed under vacuum for 15 min prior to use. A 0.50-
ml sample in 50 mM K+/Na+ phosphate buffer, pH 7.4, was placed in the sample capillary 
cell, and the same amount of buffer was placed in the reference capillary cell.  All DSC 
scans reported in this study were run at a rate of 20C/min.  After the first scan, the 
samples were cooled to the original temperature and rescanned. Since after the first scan 
the protein was completely and irreversibly denatured, no thermotransition peaks were 
observed in the second scan.  Thus the second scan could be used as a baseline.  All 
thermodynamic analyses were carried out according to the program known as CpCal 





       
EPR Measurements.  All EPR measurements were made with a Bruker EMX EPR 
spectrometer, using an aqueous quartz flat cell.  The temperature of the microwave cavity 
was controlled by circulation of cooled nitrogen gas from a modified variable 
temperature housing assembly equipped with an electric temperature sensor.         
Conventional EPR spectra were recorded with instrument settings as follows: field 
modulation frequency, 100 kHz; modulation amplitute, 8 G; microwave frequency, 9.757 
GHz; microwave power, 10.78 mW; time constant, 1310.72 ms.  Saturation transfer EPR 
spectra were recorded using the same instrument settings as those described by Thomas et 
al. (14) and Poore et al. (15).  A field modulation of 8 G and microwave frequency of 
9.757 GHz were employed with phase-sensitive detection at 100 Hz (second harmonic) 
900 out of phase.  Incident microwave power was 107.80 mW.  The phase was adjusted to 
minimize the second harmonic signal.  Approximate rotational correlation time (τ2) was 
obtained from the ratio of the two field lines (L”/L).  The calibration curve of Thomas et 
al. (14) derived from isotropic tumbling of MSL-labeled hemoglobin was used in the 
calculation. 
Other Analytical Methods.  Protein concentration was determined by the biuret 
method (16), using bovine serum albumin as the standard (assuming 1 mg/ml has an A279 
of 0.667).  Absorption spectra were measured in a Shimadzu UV-2401 PC 
spectrophotometer. 
Results and discussion 
 
Thermotropic Properties of Cytochrome caa3 and F1F0-synthase Embedded in 





       
and F1F0-synthase from alkaliphilic Bacillus pseudofirmus OF4, DSC studies were carried 
out with both complexes embedded in phospholipid (asolectin) vesicles, because these 
enzymes in protein-phospholipid vesicles should have an environment similar to that in 
membrane.  The isolated complexes, singly or in combination, were embedded in 
phospholipids vesicles by the cholate dialysis method (13).  A constant phospholipid to 
protein ratio of 1.5 was used.  The ratio between F1F0-synthase and cytochrome caa3 
varies from 0 to 1.5.  If the two lipoprotein complexes have no specific interaction, then 
no difference in DSC characteristics should be observed between phospholipids vesicles 
embedded with a mixture of two complexes and a mixture of phospholipid vesicles 
embedded with one or the other complex.  In other words, differences in the 
thermodenaturation temperatures (Tm) and enthalpy changes (∆H) would suggest 
formation of a physical complex between these two lipoproteins. 
Fig. 42. show the differential scanning calorimetric curves of alkaliphilic Bacillus 
pseudofirmus OF4 F1F0-synthase and cytochrome caa3 embedded in phospholipids singly 
or in combination.  When F1F0-synthase was incorporated into phospholipid vesicles and 
subjected to DSC analysis, an exothermic peak at 57.2 0C with the enthalpy change of -
7.3 Kcal/mmol of protein was observed (see Fig. 42.A).  Purified cytochrome caa3 also 
shows a single transition with ∆H = -17.8 Kcal/mmol of protein and Tm = 68.5 0C when  
embedded into phospholipids vesicles as shown in Fig.42.B.  As expected, when the 
mixture of protein-phospholipid vesicles formed individually from F1F0-synthase and 
cytochrome caa3 was subjected to DSC analysis under the identical condition, two 
exothermic transient peaks at 56.8 and 68.9 0C with the ∆H of -12.4 Kcal/mmol of 





       
of F1F0-synthase-phospholipid vesicles and cytochrome caa3-phospholipid vesicles.  
However, the protein-phospholipid vesicles formed from a mixture of F1F0-synthase and 
cytochrome caa3 have Tm1 = 45.5 0C and Tm2 = 74.6 0C with ∆H = -8.8 Kcal/mmol of 
protein (see Fig. 42C).  These data are significantly different from those observed with a 
mixture of phospholipids vesicles embedded individually with F1F0-synthase or 
cytochrome caa3, suggesting that there is some interaction between these two complexes. 
 Fig. 43 compares the thermodenaturation enthalpy changes of phospholipid 
vesicles formed with mixtures of cytochrome caa3 and F1F0-synthase at various molar 
ratios and of mixtures of phospholipid vesicles of individual complexes.  The value of the 
difference in ∆H increases as F1F0-synthase is increased.  The maximum difference is 
obtained when approximately one mol of F1F0-synthase per mol cytochrome caa3 is used. 
This suggests that the interaction between cytochrome caa3 and F1F0-synthase is specific. 
The accuracy of assessment of the stoichiometry between the two complexes may have 
been compromised by uncertainty concerning the intactness of each complex.  
As discussed earlier (11,17-19), the energy for the exothermic transition of an 
electron transfer complex embedded in phospholipid vesicles is derived from the collapse, 
upon thermodenaturation, of a strained interaction between unsaturated fatty 
 acyl groups of phospholipids and a protein surface on the electron transfer or other 
lipoprotein complex which was exposed, by removal of an interacting protein from a 
complex or a complex from a supermacromolecular complex, during the isolation. Such 
an interaction occurs only when a vesicle is formed.  Little exothermic transition was 
observed in mitochondrial or submitochondrial preparations because there is no such 





       
 
Fig.42. DSC curves of alkaliphile B. firmus OF4 F1F0 and cytochrome caa3 embedded in 
phospholipids singly or in combination.  The molar ratio of F1F0 and caa3 is 1 and the 
weight ratio of phospholipids to protein is 1.5 in all cases.  These vesicles are prepared by 
the cholate dialysis method.  Spectrum A shows the exothermic thermodenaturation of 0.5 
mg F1F0 embedded in phospholipid vesicles.  Spectrum B is the DSC thermogram of 
0.105 mg/ml caa3 embedded in phospholipid vesicles.  Spectrum C is the DSC profile of 
phospholipid vesicle embedded with a mixture of 0.5 mg F1F0 and 0.105 mg caa3. 
Spectrum D is a mixture of phospholipid vesicles, which include 0.5 mg F1F0 embedded 




















Fig.43. Comparison of thermodenaturation enthalpy changes of phospholipids vesicles 
formed with mixtures of cytochrome caa3 and F1F0-synthase from alkaliphile B. firmus 
OF4 at various molar ratios and of mixtures of phospholipids vesicles of individual 
complexes.  The molecular masses used in calculation of molar ratios were 517,000 and 
105, 500 daltons for F1F0-synthase and cytochrome caa3, respectively.  The ratio of 












       
 strained conditions.  When two interacting complexes are mixed together before being 
embedded in phospholipids vesicles, the exposed area on the protein surface is greatly 
diminished through the protein-protein interaction.  Therefore, less strained interaction 
occurs upon vesicle formation, and less enthalpy change of exothermic denaturation is 
observed.  It has been reported that thermodenaturation of the mitochondrial membrane 
under aerobic condition is accompanied by a heat release, which was attributed to the 
autooxidation of iron-sulfur protein (20).  This explanation is not applicable to the present 
study because there are no iron-sulfur proteins in either cytochrome caa3 or F1F0-synthase. 
 
STEPR Studies of Spin-labeled Cytochrome caa3 Embedded in Phospholipid Vesicles 
in the Absence and Presence of F1F0-synthase.  To confirm the existence of a specific 
interaction between cytochrome caa3 and F1F0-synthase, cytochrome caa3 was labeled 
with 4-maleimide-2,2,6,6-tetramethyl-1-piperidinyl-N-oxyl (MSL) as described under 
Materials and Methods.  This MSL-cytochrome caa3, which is enzymetically active, was 
embedded in phospholipids vesicles alone or together with F1F0-synthase.  The electron 
paramagnetic resonance (EPR) measurements of these electron transfer complex-
phospholipid vesicles show typical spin-immobilized spectra (see spectra A and B of 
Fig.44.).  The spectra are identical regardless of whether the protein-phospholipid 
vesicles contained only cytochrome caa3 or cytochrome caa3 and F1F0-synthase 
complexes (Fig. 44.A & B).  This suggests that the difference in mobility of the spin-label 
on cytochrome caa3, in the absence and presence of F1F0-synthase, is too small to be 
measured by conventional EPR (14).  Therefore, the protein rotational diffusion of the 





       
resonance (STEPR) because ST-EPR is an excellent method for study of the motional 
anisotropy and dynamics of spin-labeled proteins embedded in phospholipid bilayers (21-
22).  The spin correlation time, τ2, which represents the speed of motion of spin-labled 
proteins, can be calculated from the ratio of  the low field signals (L’’/L) in the ST-EPR 
spectrum (e.g., see spectra C and D of Fig. 44) (21).  The longer the rotational correlation 
time, the slower the protein moves (22).  It was reported that the rotational correlation 
time of spin-labeled protein is increased when two proteins form a supermacromolecular 
complex (11,18).   Table 5 shows the effect of additions on the rotational correlation time 
of spin-labeled cytochrome caa3.  When MSL-cytochrome caa3 mixed with F1F0-ATP 
synthase before being embedded in phospholipid vesicles, a significant increase in τ2 
(270 µs) was observed in comparison with that of MSL-cytochrome caa3 embedded in 
phospholipid vesicle alone (65 µs), indicating that MSL-cytochrome caa3 does interact 
with F1F0-ATP synthase to form supermacromolecular complex.  However, the τ2 of spin-
labeled cytochrome caa3 was not affected by the addition of cytochrome bc1 complex or 
ATP-synthase from bovine heart prior to the formation of vesicles; and the mixture of 
spin-labeled cytochrome caa3 complex and F1F0-synthase phospholipid vesicles showed 
the same τ2 as that of cytochrome caa3 phospholipid vesicles alone (see Table 7), because 
the MSL-cytochrome caa3 can’t form complex with neither mitochondrial F1F0-synthase 
nor mitochondrial bc1 complex. 
 To ensure that the observed τ2 increase upon mixing F1F0-synthase with spin-
labeled cytochrome caa3 is indeed due to the specific interaction between these two 
complexes and the formation of a binary complex, and not due to the change of protein  





       
 
Table 7. Effect of additions on the rotational correlation time (τ2) of spin-labeled 
cytochrome caa31
Preparations L’’/L τ2 (µs) 
(MSL-caa3 × PL) 0.70 65 
[(MSL-caa3 + bF1F02) × PL] 1.06 270 
[(MSL-caa3 × PL) + (bF1F0 × 
PL] 
0.71 70 
[(MSL-caa3 + mF1F03) × PL] 0.71 70 
[(MSL-caa3 + mbc14) × PL] 0.70 65 
1The molar ratio of cytochrome caa3 to other proteins used was 1:1. 
2The bF1F0 was F1F0-synthase from bacterial alkaliphile B.firmus OF4. 
3The mF1F0 was F1F0-synthase from bovine mitochondria. 


















       
labeled cytochrome caa3 with F1F0-synthase was carried out.  If a specific interaction 
between these two complexes exists, it is expected that a maximum τ2 will be obtained 
when the two components complex reaches to a specific stoichiometry.  As shown in 
Figure 45, the break point in τ2 was obtained when the ratio of F1F0-synthase to 
cytochrome caa3 approached one, which is in consistent with the number obtained from 
the DSC data.   
A similar effect of succinate-Q reductase on τ2 of spin-labeled ubiquinol-
cytochrome c reductase (18), and of F1F0-synthase on τ2 of spin-labeled cytochrome c 
oxidase from bovine mitochondria (11), has been reported from this group.    It is 
conceivable that at least part of the observed effect resulted from a change in the fluidity 
of the membrane by inclusion of protein complexes other than the spin-labeled complex.  
Also, it should be mentioned that the rotational correlation time obtained from STEPR is 
only an approximate value; it is based on the calibration curve derived from the isotropic 
motion of spin-label.  The values obtained, however, agree with those obtained by other 
methods, such as flash photolysis (23).  Although in this study our main concern is with 
the relative τ2 of spin-labeled cytochrome caa3 in the absence and presence of the F1F0-
synthase from alkaliphilic Bacillus pseudofirmus OF4, the τ2 values obtained are in 
agreement with the DSC data. 
 From the results of DSC and STEPR experiments, we conclude that cytochrome 
caa3 and F1F0-synthase from alkaliphilic Bacillus pseudofirmus OF4 may exist as a 
supermacromolecule complex in the membrane.  This conclusion differs significantly 
from the free diffusible model of electron transfer complexes derived from results of 





       
(25).  However, it has been clearly established that some mitochondrial electron-transfer 
complexes specifically interact to form supermolecular structures called supercomplexes 
from the work on the yeast Saccharomyces cerevisiae (26,27), beef (11,18,27,28), and 
plants (29-32).  Similar supermolecular structures were also described for the respiratory 
chains of bacteria (33-37).  The roles that have been attributed to respiratory 
supercomplexes are substrate-channeling, catalytic enhancement, sequestration of reactive 
intermediates (27), stabilization of protein complexes (38), increasing the capacity of the 
inner mitochondrial membrane for protein insertion (26), and generating mitochondrial 
cristae morphology (39).  Furthermore, the dynamic formation of such supercomplexes is 
speculated to serve some regulatory function in the energy generation in mitochondria 
from plants (29) and beef (11,29).  Similarly, the formation of a supermacromolecule 
complex between cytochrome caa3 and F1F0-synthase from alkaliphilic Bacillus 
pseudofirmus OF4 may help control energy generation in this alkaliphilic bacterium.  The 
formation of supermacromolecule complexes from some electron transfer and F1F0-
synthase complexes indicates that some of these complexes do not follow the random 










Fig.44. EPR spectra of spin-labeled alkaliphile B. firmus OF4 cytochrome caa3 in the 
absence and presence of OF4 F1F0-synthase complex.  Spectra A and B are conventional 
EPR spectra of spin-labeled OF4 cytochrome caa3 embedded in phospholipid vesicles in 
the absence or presence of OF4 F1F0-synthase complex.  Spectra C and D are the 
saturation transfer EPR spectra of the same samples.  The protein concentrations were 6 







       
 
Fig.45. Effect of F1F0-synthase on STEPR of spin-labeled cytochrome caa3. Increasing 
amounts of F1F0-synthase were added to a constant amount of spin-labeled cytochrome 
caa3.  The solutions were incubated for 60 min at 4 oC before embedded in phospholipids 
vesicles. 1.5 mg of phospholipid/mg of protein was used.  L’’/L was calculated from the 
saturation transfer EPR spectra of each sample. Instrument settings are given under 
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Scope and Method of Study:  Although bacterial enzymes have simpler subunit 
composition than their mammalian counter parts, the sizes of core subunits (cytochrome 
b, ISP and cytochrome c1) are generally larger.  Are these extra fragments required for 
bacterial bc1 complex?  To answer this question, we studied two of these extra 
fragments through the molecular genetic manipulation of Rhodobacter sphaeroide (R.S.) 
bc1 complex at various positions of residues 421- 445 in cytochrome b and residues 96-
107 in ISP. bc1 activity assay, SDS-PAGE, western-blotting, DSC, and EPR, were used 
to characterize the mutants.  To elucidate the quinone binding site of the bc1 complex, 
we generated and characterized some mutants in R.S. bc1 complex based on the 
structural analysis of the low resolution of co-crystal of bovine bc1 complex with 5-Br-
Q0C10.  There is a hypothesis alkaliphile oxidative phosphorylation at very alkaline pH 
values involves the required respiratory chain proton pumping to the bulk phase to 
establish a membrane potential and also involves the use of one or more specific 
respiratory chain complexes to transfer protons to F0 sector of the F1F0 ATP-synthase 
during dynamic protein-protein interaction. To test this hypothesis, the interaction 
between cytochrome caa3 and F1F0-ATP synthase from alkaliphilic Bacillus       
pseudofirmus OF4 was studied by using DSC and saturation transfer EPR.  
Findings and Conclusions:  Our data demonstrated that both extra fragments are required for 
bacterial bc1 complex.  The first 12 residues (residues 421- 432) of the C-terminal extra 
fragment of cytochrome b in the cytochrome bc1 complex from Rhodobacter sphaeroides are 
essential for maintaining structural integrity of the bc1 complex.  The ISP extra fragment 
(residues 96-107) is found to be required for the structural stability of ISP in this bacterial bc1 
complex.  Both of these findings suggest that these two extra fragments possess the 
supernumerary subunit function in stabilizing the structure of the bacterial complex.  Quinone 
binding site is an ongoing project, we haven’t got very good results yet.   From the results of 
DSC and ST-EPR experiments, we concluded cytochrome caa3 and F1F0-synthase from 
alkaliphilic Bacillus pseudofirmus OF4 exist as a supermacromolecular complex in the 
membrane. 
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